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SUMMARY 
Campylobacter jejuni is an enteric bacterium that causes human gastroenteritis worldwide. 
Some C. jejuni strains exhibiting human ganglioside-like lipooligosaccharide (LOS) 
structures, such as GM1 ganglioside, can induce an autoimmune neuropathy of the peripheral 
nervous system known as the Guillain-Barré syndrome (GBS). This GBS-inducible 
determinant is encoded by a gene cluster, which shows a high degree of variation among C. 
jejuni strains. The experiments presented in this thesis were conducted to give a better insight 
into the LOS synthesis genes in relation to the pathophysiology of C. jejuni. Firstly, a C. 
jejuni strain without GM1-like molecules was shown to be able to take up large DNA 
fragments, including LOS synthesis genes, from a strain expressing GM1-like molecules and 
consequently be transformed into a number of potential GBS-inducible transformants, which 
exhibited a high degree of genetic and phenotypic diversity. The ability of C. jejuni to take up 
and integrate foreign DNA explains the genome plasticity observed in this pathogen. 
Secondly, while attempting to analyse transcription of the LOS gene cluster, neither published 
methods nor any commercially available kits for RNA isolation could produce DNA-free 
RNA from C. jejuni. Combinations of these methods were trialled and only the combination 
of RNAzolB, TURBO DNase treatment, and acid phenol extraction was able to produce 
DNA-free RNA. The RNA isolated from most C. jejuni strains showed different RNA 
patterns to that of other bacteria. In addition the RNA from C. jejuni seemed closely 
associated with DNA compared to RNA from other organisms. This might be caused by 
species-specific DNA conformation or chromatin structure. Thirdly, bidirectional 
transcription was observed in the LOS gene cluster. Both DNA strands were transcribed but 
transcription of the non-coding strands was at a lower rate, and both sense and antisense 
transcripts of each LOS gene tested were responsive to acid stress. This unusual transcription 
might have a potential effect on the expression of the GBS-inducing determinant. Finally, one 
of the LOS genes, the htrB gene, was further analysed. It was shown that expression of the 
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htrB gene affects morphology, viability, growth ability, and sensitivity to stress environments. 
These results showed that the LOS molecule of C. jejuni is involved in many processes and is 
an important molecule for survival. 
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GENERAL INTRODUCTION 
1. General characteristics of Campylobacter jejuni 
The word Campylobacter is derived from the Greek word “campylos” which means curve and 
the word “bactron” which means rod. C. jejuni is a microaerophilic and capnophilic 
bacterium, which can appear as curved rods, spiral rods, straight rods, and/or coccus forms 
(pleomorphism). It is motile by means of a single unsheathed polar flagellum at one or both 
ends. Motility appears as a unique darting and cork-screw-like movement. C. jejuni is mainly 
found in the intestinal tracts of animals, such as poultry and swine (77). 
The genome sequence of C. jejuni strain 11168 has been recently established (81). It has a 
circular chromosome of 1,641,481 bp (30.6% G + C), which is predicted to encode 1,654 
proteins and 54 stable RNA species. Unusually, the genome has no insertion sequences or 
phage-associated sequences and very few repeat sequences. One of the most striking features 
of the genome is the presence of hypervariable sequences. In addition, the short 
homopolymeric runs of nucleotides are commonly found in genes encoding the biosynthesis 
or modification of surface structures, or in closely linked genes of unknown function. Whole 
genome comparative analysis among C. jejuni strains suggests that genetic diversity is a 
major trait of this bacterium (18).  
2. Diseases caused by C. jejuni 
2.1. Campylobacteriosis 
C. jejuni causes gastroenteritis (campylobacteriosis) in humans. It is predominantly 
characterised by inflammatory diarrhoea, abdominal pain, and/or fever. Infection of humans 
mainly occurs by consumption of contaminated poultry products, milk, and water (77). 
2.2. Guillain-Barré syndrome 
Guillain-Barré syndrome (GBS) is an autoimmune neuropathy of the peripheral nervous 
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system that is the most serious disease complication following bacterial and viral infections. 
Causative organisms include C. jejuni, cytomegalovirus, Epstein-Barr virus, and Mycoplasma 
pneumonia. GBS is characterised by weakness, usually symmetrical, evolving over a period 
of several days or more. Affected persons rapidly develop weakness of the limbs, weakness of 
the respiratory muscles, and areflexia (loss of reflexes) (72, 116).  
GBS consists of at least 4 subtypes of acute peripheral neuropathy; acute inflammatory 
demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN), 
acute motor and sensory axonal neuropathy (AMSAN), and Fisher’s syndrome (FS) (42). 
AIDP subtype resembles experimental autoimmune neuritis, and there is evidence for the 
involvement of antibodies and complement. AMAN and AMSAN subtypes are caused by 
antibodies to gangliosides on the axolemma that target macrophages to invade the axon at the 
node of Ranvier. About a quarter of patients with GBS have had a recent C. jejuni infection, 
and axonal forms of the disease are especially common in these people. The FS subtype is 
especially associated with antibodies to GQ1b, which damages the motor nerve terminal in 
vitro by a complement-mediated mechanism.  
3. Prevalence of campylobacteriosis and Guillain-Barré syndrome 
Children under five years old are most susceptible to Campylobacter infections (16). Among 
this group, the rate of illness caused by C. jejuni is higher than that caused by Vibrio spp., 
Salmonella spp., Shigella., pathogenic Escherichia coli, Aeromonas spp., and Plesiomonas 
spp. [M.Sc. thesis (V. Phongsisay), Faculty of Tropical Medicine, Mahidol University, 
Thailand].  
The prevalence of GBS is fairly uniform at between one and four cases per 100,000 
throughout the world, and men are about 1.5 times more likely to be affected than women (72, 
103).  
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4. Treatment of campylobacteriosis and Guillain-Barré syndrome 
In general, Campylobacter enteritis does not warrant antimicrobial therapy. Although 
campylobacteriosis is a self-limiting disease, treatment can decrease duration and severity of 
the illness as well as potentially prevent its complicating disease, GBS. Antibiotic treatment is 
necessary for patients who are acutely ill with enteritis, have persistent fever, and bloody 
diarrhoea. When antimicrobial therapy is indicated, erythromycin is the preferred drug for 
treatment. Although the incidence of GBS is rare, special care is needed for GBS patients to 
prevent and manage the potentially fatal complications of the disease. Plasma exchange and 
intravenous immunoglobulin are the treatment strategies for GBS patients (72, 112). 
5. Pathogenesis of campylobacteriosis  
Presently, the pathogenesis of campylobacteriosis is not fully understood; however, the 
disease development requires the resistance of C. jejuni to stress environments in the human 
gastrointestinal tract such as acid, bile, and osmotic pressure. In addition, the interaction 
between host factors and bacterial virulence factors is a crucial process for disease 
development. As the same C. jejuni isolates are observed in both diarrhoeal patients and 
healthy persons (13), host factors are expected to play an important role in disease 
development. However, its role in relation to campylobacteriosis has not yet been 
characterised.  Furthermore, a number of antigenic determinants/bacterial components are 
known to contribute to the virulence of C. jejuni. These include CadF (52), JlpA (43), PEB1 
(83), CiaB (53), plasmid (8),  flagella (107), cytotoxin (56), capsule (9), and LOS (24). 
5.1. CadF 
The cadF gene encodes a protein of 326 amino acids with a calculated molecular mass of 37 
kDa (CadF) (52). CadF is a conserved outer membrane protein of C. jejuni that specifically 
binds to the fibronectin of the extracellular matrix of epithelial cells. The deduced amino acid 
sequence exhibits 52% similarity and 28% identity to the root adhesin protein from 
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Pseudomonas fluorescens. Mutagenesis and in vivo experiments have shown that the C. jejuni 
CadF protein appears to be required for the colonisation of newly hatched leghorn chickens 
(119).  
5.2. CiaB 
C. jejuni secretes a set of proteins termed the Campylobacter invasion antigens (Cia proteins). 
These proteins are secreted from the flagellar export apparatus and are required for the 
internalisation of C. jejuni into cultured mammalian cells. For example, the ciaB gene that is 
designated the Campylobacter invasion antigen B encodes a protein of 610 amino acids with a 
calculated molecular mass of 73 kDa (CiaB). The deduced amino acid sequence of the CiaB 
protein shares similarity with type III secretion proteins associated with the invasion of host 
cells from other bacterial pathogens. Mutagenesis and in vitro experiments have shown that 
the C. jejuni ciaB gene is required for the secretion process and the efficient entry of this 
bacterium into a host cell (53, 54).  
5.3. JlpA 
The jlpA gene, a 1,116 bp open reading frame, is a species-specific lipoprotein of C. jejuni. It 
encodes a polypeptide (JlpA) of 372 amino acid residues with a molecular mass of 42.3 kDa. 
JlpA contains a typical signal peptide and lipoprotein processing site at the N-terminus. JlpA 
is a lipoprotein that is loosely associated with the cell surface. Mutagenesis and in vitro 
experiments have shown that JlpA is a C. jejuni adhesin involved in adherence (43).  
5.4. Peb1 
Peb1 is a C. jejuni adhesion protein that is a homolog of cluster 3 binding proteins of bacterial 
ABC transporters and is identical to the previously identified cell-binding factor 1, CBF1, in 
C. jejuni. Peb1 is encoded by the 0.78 kb peb1A locus encoding a 259-residue polypeptide 
with a molecular mass of 28 kDa. Mutagenesis experiments have shown that the C. jejuni  
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peb1A locus plays an important role in epithelial cell interactions and in intestinal colonisation 
in a mouse model (82, 83). 
5.5. Plasmids 
A number of C. jejuni isolates have been shown to possess plasmids between 30 and 40 kb in 
size (87). The C. jejuni strain 81-176 harbours two plasmids (pTet and pVir), each 
approximately 35 kb in size (8). The first plasmid, pTet, carries the tetO gene. Transfer of the 
tetO gene among C. jejuni strains has been demonstrated to occur both in vivo (chicken) and 
in vitro (7, 87). Since chicken products are frequently reported as the infectious source of C. 
jejuni (77), the rapid and spontaneous transfer of the tetO gene potentially contributes to the 
high prevalence of tetracycline resistance in both Campylobacter strains isolated from 
chickens and humans. The second plasmid, pVir, contains four open reading frames (ORFs). 
ORF1 through ORF3 encode proteins that
 
display significant identity to the products of the 
comB1, comB2,
 
and comB3 genes, respectively, of H. pylori P1, which are involved
 
in DNA 
uptake via natural transformation in H.
 
pylori (41). Similarly, mutation of the plasmid gene, 
comB3, in C. jejuni 81-176 causes reduced adherence and invasion of INT407 cells and a 
reduced natural transformation frequency (8). ORF4 encodes a protein whose highest identity 
match is to the H. pylori protein JHP1316/HP1421. This H. pylori protein is a member of a 
paralogous
 
family that has significant identity
 
to VirB11 of the Agrobacterium type IV 
secretion system (96, 106). The H. pylori VirB11-like paralogous family (HP0525 and
 
HP1421) has been proposed to function in a type IV secretion system
 
required for virulence 
(17). In C. jejuni 81-176, mutation of a virB11 homolog has resulted in reduced adherence 
and invasion of INT407 cells and reduced virulence in the ferret diarrhoeal disease model (8).  
5.6. Flagella 
Flagella-mediated motility is recognised to be one of the major factors contributing to 
virulence in C. jejuni. C. jejuni has two almost identical flagellin genes, which encode the 
structural subunit of the flagellum. The two flagellin genes, flaA and flaB, each 1.7 kb, are 
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located
 
adjacent to one another, but they have different promoters (36, 75). The flaB gene is 
not needed for motility, while the flaA gene is essential for motility (107), and plays a role in 
colonisation (111).  
5.7. Cytotoxin 
C. jejuni has been demonstrated to possess a cytolethal distending toxin (CDT) that causes 
cells to arrest in the G (2)/M transition phase of the cell cycle (56). CDT activity requires the 
function of three genes: cdtA, cdtB, and cdtC. It has been proposed that CDT is a tripartite 
toxin consisting of CdtB as the enzymatically active subunit, with CdtA and CdtC as the 
heterodimeric B subunit required for the delivery of CdtB.   
5.8. Capsule 
Capsular polysaccharides (CPSs) are found on the surface of a large number of bacterial 
species. CPSs are known to play an important role in bacterial survival and persistence in the 
environment and often contribute to pathogenesis. The recent genomic sequencing of C. jejuni 
NCTC 11168 has revealed the presence of a cluster of genes encoding proteins with sequence 
similarity to proteins involved in the transport of type II/III capsules (81). Analysis of capsule 
synthesis gene clusters from different C. jejuni strains shows a high degree of variation among 
strains, ranging from 15 to 34 kb (47). Comparison of the determined CPS sequences of the 
HS:1, HS:19 and HS:41 strains with the sequenced strain, NCTC11168 (HS:2), provides 
evidence for multiple mechanisms of structural variation including exchange of capsular 
genes and entire clusters by horizontal transfer, gene duplication, deletion, fusion, and 
contingency gene variation. In contrast, the HS:23, HS:36 and HS:23/36 CPS sequences were 
highly conserved (47). Karlyshev et al.  (48) have shown that site-specific insertional 
mutagenesis of kpsM, kpsS or kpsC (capsule synthesis genes) in several strains results in the 
loss of a high-molecular-weight glycan (capsule) (48). Moreover, Karlyshev and colleagues 
(48) have also demonstrated that kps mutants in five distinct serogroups of C. jejuni lost the 
ability to be typed in the Penner scheme (84), indicating that capsule, rather than 
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lipooligosaccharide, as previously thought, is the serodeterminant molecule. Furthermore, the 
capsule is involved in the virulence of C. jejuni since a capsule-deficient
 
C. jejuni 81-176 
kpsM mutant exhibits an increased surface
 
hydrophobicity and serum sensitivity, a reduced 
ability to
 
invade INT407 cells, and is less virulent in a ferret diarrhoeal
 
disease model (9). 
5.9. Lipooligosaccharide 
The lipooligosaccharide (LOS) of C. jejuni is a major surface molecule. It consists of two 
parts, the core oligosaccharide (Fig. 1) and the lipid A (Fig. 2). The core oligosaccharide is 
divided into the inner core and the outer core. In some strains of C. jejuni, the core 
oligosaccharide resembles human gangliosides such as GM1, GM2, and GQ1b (Fig. 1) (3-5, 
32, 62, 93). This molecular mimicry can induce GBS (117). In addition, the outer core part of 
the LOS molecule plays a role in the virulence of C. jejuni (24), whilst the lipid A of the LOS 
molecule possesses endotoxic properties (73). 
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Figure 1.   Outer regions of the LOS structures expressed by C. jejuni strains [from Gilbert et 
al. 2002 (32)]. 
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Figure 2. Lipid A structure of C. jejuni NCTC 11168 [from Szymanski et al. 2003 (102)].  
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6. Pathogenesis of Guillain-Barré syndrome 
Presently, the pathogenesis of GBS is not fully understood; however, it is known that the 
molecular mimicry that exists between the LOS of some C. jejuni strains and the human 
gangliosides in nerve tissue can induce GBS. In addition, as the same C. jejuni isolates have 
observed in both GBS and non-GBS patients (112), host factors are expected to play an 
important role in GBS development.  
7. Lipooligosaccharide synthesis gene cluster 
The LOS of C. jejuni is encoded by two gene clusters, wlaI and wlaII. The wlaI gene cluster is 
highly conserved in C. jejuni (25, 81). It is involved in both protein glycosylation and LOS 
synthesis (24, 25). In C. jejuni strain 81116, it contains 12 consecutive genes: galE, wlaB, 
wlaC, wlaD, wlaE, wlaF, wlaG, wlaH, wlaI, wlaK, wlaL, and wlaM (25). Their putative 
functions were previously described by Fry and colleagues (24, 25) and are shown in Table 1. 
In contrast, the wlaII gene cluster exhibits a high degree of genetic variation among strains 
(32, 80)  (Fig. 3, also see Table 2). Some of these genes have been experimentally 
characterised and found to be involved in the induction of GBS and the biosynthesis of LOS 
and capsule. 
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Table 1. Deduced proteins present in the wlaI gene cluster of C. jejuni 81116 and their 
homologues (25) 
C. jejuni 
protein 
Similar Protein 
(% identity) 
Organism Putative function 
Accession 
no. 
GalE† GalE (37.5) Haemophilus influenzae UDPglucose 4-epimerase A64063 
 GalE (36.3) Neisseria  meningitidis UDPglucose 4-epimerase S39638 
WlaB HetA (30.1) Anabaena sp. Polysaccharide involvement P22638 
 HlyB (30.1) Escherichia coli Export haemolysin P08716 
WlaC TrsD (28.8) Yersinia  enterocolitica Glycosyltransferase S51263 
 AmsD (27.4) Erwinia  amylovora Glycosyltransferase S52144 
WlaD Orf8.7 (27.2) Yersinia  pseudotuberculosis Abequosyltransferase L01777 
 TrsB (23.3) Yersinia  enterocolitica Glycosyltransferase S51261 
WlaE AmsD (25.1) Erwinia  amylovora Glycosyltransferase S52144 
 TrsD (24.9) Yersinia  enterocolitica Glycosyltransferase S51263 
WlaF STT-3 (19.5) Caenorhabtidis  elegans Oligosaccharyltransferase P46975 
 Wzy (18.8) Escherichia  coli O-antigen polymerase P37748 
WlaG CpsF (30.8) Proteus  mirabilis Glycosyltransferase L36873 
 RfbF (27.1) Serratia  marescens Galactantransferase L34167 
WlaH WbaP (39.5) Salmonella  enterica Galactosyltransferase first step P26406 
 WbaP (38.5) Haemophilus  influenzae Galactosyltransferase B64099 
WlaI NeuD (28.1) Escherichia  coli Polysialic acid capsule 
synthesis 
U05248 
 LpxD (26.6) Salmonella  enterica Acyltransferase P18482 
WlaK‡ RfbE (32.2) Vibrio  cholerae Perosamine synthetase S28471 
 DegT (29.0) Bacillus  stearothermophilus Transamination P15263 
WlaL CapD (38.5) Staphylococcus  aureus Capsule synthesis P39853 
 TrsG (37.5) Yersinia  enterocolitica Acetylgalactosamine synthesis S51266 
WlaM AcfB (26.9) Vibrio  cholerae Accessory colonization factor L25660 
†, Upstream of the galE gene is the Cj1132c gene encoding a hypothetical protein Cj1132c 
that is present in both C. jejuni strains 81116 and 11168; ‡, upstream of the wlaK gene is the 
wlaJ gene encoding a putative integral membrane protein that is present in strain 11168 but 
not 81116 (25, 81). 
 
 14
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. LOS synthesis gene clusters of C. jejuni. The GenBank accession numbers are AL111168 for NCTC 11168 (81), Y11648 for 81116 (25), 
AY297047 for HB 93-13 (74), AF215659 for ATCC 43432 (32), AF401529 for ATCC 43449 (32), AL139077 for NCTC 11168 (81), AF400669 for LIO87 
(33), AF343914 and AJ131360 for 81116 (26, 76), AY434498 for RM1170 (79, 80), AY436358 for ATCC 43437 (80), AY800272 and AF411225 for 
ATCC 43431 (31, 80). *, strain 81116 does not possess the wlaJ gene (25). 1-39 are ORFs; underline, partial ORF 26. 
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Table 2. Functions of the genes found in the wlaII-LOS synthesis gene clusters of C. jejuni 
strains (also see Figure 3) 
ORF* Homologous gene Function (reference) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
waaC 
htrB (wlaNA) 
wlaNC 
wlaND 
cgtA 
cgtB 
cstII 
neuB (neuB1) 
neuC (neuC1) 
neuA (neuA1) 
wlaVA 
wlaQA (waaV) 
waaF 
Cj1137c 
Cj1138 
Cj1145c 
Heptosyltransferase I (45) 
Putative Lipid A biosynthesis acyltransferase (32, 81) 
Putative glucosyltransferase (32, 81) 
Putative galactosyltransferase (32, 81) 
β-1, 4-N-Acetylgalactosaminyltransferase (29, 35) 
β-1, 3-Galactosyltransferase (29, 62) 
α-2, 3 or α-2, 3/ α-2, 8-sialyltransferase (29, 35) 
Sialic acid synthase (63) 
N-Acetylglucosamine-6-phosphate 2-epimerase (35) 
CMP-Neu5Ac synthetase (32) 
Putative acetyltransferase (32, 81) 
Putative glycosyltransferase (32, 81) 
Heptosyltransferase II (76) 
Putative glycosyltransferase (32, 81) 
Putative glycosyltransferase (32, 81) 
Hypothetical protein (32, 81) 
*, Only the ORFs (1-16) are summarised accoding to the available data from the genome 
sequence of C. jejuni NCTC 11168 (81) and the publications described in the text.  
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7.1. galE 
The C. jejuni galE gene is located in the wlaI gene cluster (25). It encodes a UDP-glucose 4-
epimerase, which catalyses the interconversion of UDP-galactose and UDP-glucose involved 
in the synthesis of the LOS core region (24). Mutation of the galE gene in C. jejuni results in 
truncated LOS, reduced adherence and invasion of INT407 cells, and reduced natural 
transformation frequency, indicating that the galE gene is involved in virulence. However, the 
C. jejuni galE mutant is still able to colonise chickens to the same level as the parent strain, 
and the serum resistance and hemolytic activity of this mutant does not change compared to 
the parent strain (24). In addition, in vivo experiments have shown that the galE gene is 
essential for the formation of human ganglioside-like LOS structure (94), which can induce 
GBS (117).  
7.2. waaC 
The C. jejuni waaC gene is located in the wlaII gene cluster. Kanipes et al. (45) have 
experimentally shown that this gene encodes a heptosyltransferase I that catalyses the transfer 
of the first L-glycero-D-manno-heptose residue to a 3-deoxy-D-manno-octulosonic residue in 
the (Kdo)-lipid A (45). Mutagenesis experiments have demonstrated that the C. jejuni waaC 
gene contributes to the synthesis of both LOS inner core and capsule carbohydrate (45).  
7.3. cstII, cgtA, cgtB,  neuC, and neuA 
Phase variation of the C. jejuni cgtB gene affects the ganglioside-like LOS structure (62). The 
cgtB homologous gene in C. jejuni NCTC 11168 encodes a β-1, 3 galactosyltransferase, 
which is responsible for converting GM2-like to GM1-like LOS structures. It is essential for 
the formation of human ganglioside-like LOS structure. In C. jejuni NCTC 11168, the 
presence of an intragenic homopolymeric tract (poly G) renders the expression of a functional 
cgtB gene product phase variable, resulting in distinct cell populations with alternate GM1 or 
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GM2 ganglioside-mimicking LOS structures. Similarly, phase variation of the cgtB 
homologous gene is also observed in C. jejuni NCTC 12500. 
Phase variation in the LOS-synthesis genes of C. jejuni affects not only LOS structure but 
also its invasion capacity (37). It has been observed that a population of cells of C. jejuni 
strain 81-176 produces a mixture of LOS cores, which exhibit primarily structures mimicking 
GM2 and GM3 gangliosides, with few structures mimicking GD1b and GD2. These multiple 
LOS structures are due to the presence of a homopolymeric tract of G residues within the cgtA 
gene (orf 5.2), a putative β-1, 4-N-acetylgalactosaminyltransferase (GalNAc), which affects 
the length of the ORF resulting in a change in LOS structure from GM2 to GM3 ganglioside 
like structure. Site-specific mutation of the cgtA gene in 81-176 resulted in a major LOS core 
structure lacking GalNAc that exhibits GM3 ganglioside and increased invasion of INT407 
cells. In comparison, site-specific mutation of the neuC1 gene resulted in the loss of sialic 
acid in the LOS core and a reduced resistance to normal human serum, but it had no affect on 
invasion of INT407 cells. 
Sialylation of the LOS cores affects immunogenicity and serum resistance of C. jejuni strain 
MSC57360 (35). The cstII gene encodes a sialyl transferase and the neuC gene (neuC1) 
encodes an N-acetylmannosamine synthetase that is part of the biosynthetic pathway of N-
acetylneuraminic acid (NeuNAc). The C. jejuni strain MSC57360 lacking the cstII or neuC 
gene exhibits identical phenotypes. The LOS cores of these mutants exhibit an increased 
electrophoretic mobility, the loss of reactivity with cholera toxin (CT), and an enhanced 
immunoreactivity with a hyperimmune polyclonal antiserum generated against whole cells of 
C. jejuni MSC57360. In comparison, mutation of the cgtA gene [orf 5, fused with orf10 
(neuA1), Fig. 3] resulted in LOS cores intermediate in electrophoretic mobility between that 
of the parent and the mutants lacking NeuNAc, the loss of reactivity with CT, and a reduced 
immunoreactivity with hyperimmune antiserum. In addition, a mutant with a nonsialylated 
LOS core is more sensitive to the bactericidal effects of human sera than the parent or the 
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mutant lacking GalNAc (35). Interestingly, mutation of the cgtA gene resulted in the loss of 
GalNAc but not NeuNAc from the LOS core (35). Possibly, the fusion protein has either lost 
CMP-NeuNAc synthetase activity or there are additional copies of genes encoding enzymes 
with the same function (35). Indeed, NCTC 11168, in addition to containing Cj1143 (neuA1), 
contains two other copies of neuA alleles, Cj1311 (neuA2) and Cj1331 (neuA3 or ptmB). The 
neuA3 or ptmB allele has been shown to be involved in posttranslational modification of 
flagellin of Campylobacter coli VC167 (34), but the role of this gene in LOS biosynthesis in 
VC167, whose core is uncharacterised, has not yet been elucidated.  
7.4. neuB 
The C. jejuni neuB gene is involved in the synthesis of both LOS and flagella (63). In C. 
jejuni NCTC 11168, there are three N-acetyl neuraminic acid (NANA) synthetase genes 
termed neuB1 (neuB, Table 2), neuB2, and neuB3. The neuB1 gene is mapped in the wlaII 
gene cluster, while the others are located outside the LOS gene cluster. Mutation of the neuB1 
gene affects LOS core structure, while mutation of the neuB2 and neuB3 genes does not affect 
LOS, but the neuB3 mutant is aflagellate and non-motile. No phenotype change is evident for 
neuB2 mutants in strain NCTC 11168, but for strain G1 the flagellin protein from the neuB2 
mutant shows an apparent reduction in molecular size relative to the wild type.  
7.5. waaF 
The C. jejuni waaF gene is located in the wlaII gene cluster. It encodes a heptosyltransferase 
II, which catalyses the transfer of the second L-glycero-D-manno-heptose residue to the core 
oligosaccharide moiety of the LOS molecule. Mutation of the waaF gene in C. jejuni resulted 
in the production of a truncated core oligosaccharide, the failure to bind specific ligands, and 
the loss of serum reactive GM1, asialo-GM1, and GM2 ganglioside epitopes. In contrast to 
the waaC gene, mutation of the waaF gene does not affect the higher-molecular-weight 
polysaccharide supporting the production of a LOS-independent capsular polysaccharide by 
C. jejuni (76).  
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SCOPE OF THE PRESENT STUDY 
This thesis describes the characterisation of the LOS synthesis gene cluster in relation to the 
pathophysiology of C. jejuni as follows:   
Chapter I:  Exchange of LOS synthesis gene clusters and adjacent regions between non-GBS   
and GBS-inducing C. jejuni strains. 
Chapter II: Evaluation of current RNA isolation methods for transcriptional analysis of the 
wlaII-LOS synthesis gene cluster from C. jejuni strains.  
Chapter III: Transcription analysis of the wlaII-LOS synthesis gene cluster from the GBS-
inducing C. jejuni strain HB 93-13. 
Chapter IV: Physiological examination of the pleiotropic functions of the LOS-synthesis 
htrB gene of C. jejuni HB 93-13. 
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CHAPTER I 
Exchange of LOS synthesis gene clusters and adjacent regions between non-
GBS and GBS-inducing C. jejuni strains 
 
 
 
 
 
 
 
The study described in this chapter was published in 
Infection and Immunity 2006 
74: 1368-1372 
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ABSTRACT 
Human ganglioside-like structures, such as GM1, found on some Campylobacter jejuni strains 
have been linked to inducing the Guillain-Barré syndrome (GBS). This study investigated 
interstrain exchange of the C. jejuni LOS synthesis genes via natural transformation. A C. 
jejuni strain 81116 (GM1 negative) was incubated with genomic DNA isolated from the C. 
jejuni O:4 wlaVA mutant (GM1 positive and kanamycin resistant). One hundred and fifty 
kanamycin resistant transformants were randomly picked and immunologically probed with 
the cholera toxin B subunit (CTB), which is GM1 specific. Surprisingly, 145 of the 150 
transformants reacted with CTB while only 5 transformants were CTB-negative. PCR-RFLP 
analysis showed that the host strain 81116 acquired various DNA fragments (up to 45 kb), 
including LOS synthesis genes, from donor DNA using various integration points that mostly 
located outside the LOS gene cluster. Consequently, strain 81116 transformed into a number 
of GM1-expressing transformants, which exhibited a high degree of variation in their LOS 
gene clusters and adjacent regions. Moreover, PFGE analysis revealed that horizontal 
exchange of large DNA fragments (up to 388 kb) occurred throughout the genome of strain 
81116. Furthermore, silver staining of LOS isolated from the transformants after SDS-PAGE 
showed various LOS patterns and most of them were different from the LOS pattern of parent 
strain 81116. Therefore, these results showed that a C. jejuni strain without GM1-like 
molecules can transform into a number of potential GBS-inducible strains, which exhibit a 
high degree of genetic and phenotypic diversity, following natural transformation.  
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INTRODUCTION 
The Guillain-Barré syndrome (GBS) is a postinfectious autoimmune neuropathy that can 
occur following campylobacteriosis. Affected persons rapidly develop weakness of the limbs, 
weakness of the respiratory muscles, and areflexia (72). Presently, the pathogenesis of GBS is 
not fully understood. However, since similar C. jejuni strains have been isolated from both 
GBS and non-GBS patients (112), host factors also play an important role in GBS 
development. In addition, a study by Yuki et al. (117) showed that rabbits, which had been 
sensitised with C. jejuni lipooligosaccharide (LOS), developed anti ganglioside-GM1 
immunoglobulin G (IgG) antibodies and flaccid limb weakness (117). Paralysed rabbits had 
pathological changes in their peripheral nerves that were identical to those present in GBS 
(117). Moreover, immunisation of mice with C. jejuni LOS generated a monoclonal antibody 
(MAb) that reacted with GM1 and bound to human peripheral nerves. The MAb and anti-
GM1 IgG from GBS patients blocked muscle action potentials in a muscle-spinal cord 
coculture (117). These results indicated that anti-GM1 antibodies can cause muscle weakness 
(117), and the molecular mimicry that exists between the human gangliosides, including 
GM1, and the C. jejuni LOS is one of the GBS-inducible determinants. 
The C. jejuni LOS is partly encoded by the wlaII gene cluster that has been shown to exhibit a 
high degree of variation among strains (32, 80). Presently, the function of individual LOS 
genes is not fully understood; however, the wlaND, cgtA, cgtB, cstII, neuB, neuC, neuA, and 
waaF genes are essential for the formation of human ganglioside-like LOS structures which 
can induce GBS (35, 37, 62, 63, 76, 117). Upstream of the waaC gene, the wlaI gene cluster is 
found which is highly conserved in C. jejuni strains (25, 81). The wlaI locus is mainly 
involved in protein glycosylation, although at least one gene, galE, is also involved in LOS 
synthesis (24).  
Natural transformation is the ability of a bacterium to take up genetic material, which can be 
integrated into the chromosomal DNA via homologous recombination. Exchange of LOS 
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synthesis genes was recently shown for a C. jejuni strain isolated from a patient with GBS 
(30). This study hypothesised that a non-GM1 strain could take up LOS synthesis genes in 
vitro and potentially become a GBS-inducible strain. 
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MATERIALS AND METHODS 
Bacterial growth 
C. jejuni was grown on Columbia agar plates supplemented with 5% defribinated horse blood 
under microaerobic conditions (5% O2, 10% CO2, and 85% N2) at 37ºC for 16 h. E. coli was 
grown in Luria-Bertani (LB) broth or agar at 37˚C for 16 h. Media were supplemented with 
kanamycin (50 µg/ml) when appropriate. 
Preparation of whole cell lysates 
Bacteria were grown as previously described. Bacterial cells were harvested in 1 ml of PBS 
and centrifuged at 3,300 × g (6,000 rpm) for 6 min. The pellet was resuspended in 2 ml of 
PBS and then homogenised on ice at 70% amplitude for at least 3 times for 20 s (each) with 
20 s interval using a Branson Digital Sonifier. The protein concentration was determined 
using a modified Lowry procedure (14).  
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)  
SDS-PAGE was used for analysis of individual proteins/components presented in bacterial 
whole cell lysates. A separating gel (12%) was prepared by mixing the following: 4.78 ml of 
MilliQ water, 3.75 ml of 1.5 M Tris-HCl (pH 8.8), 6 ml of 30% stock acrylamide solution, 
150 µl of 10% (w/v) SDS.  Gel polymerisation was initiated by adding 50 µl of 10% 
ammonium persulfate in MilliQ water (freshly prepared) and 7.5 µl of TEMED.  The gel was 
poured gently into the space formed between two glass plates to the level of 1-2 cm below the 
upper edges of the plates. The gel was overlaid with MilliQ water and allowed to polymerise 
for at least 30 min without disturbance. The stacking gel (4%) was prepared in the same 
manner as described in the separating gel. It consisted of 3 ml of MilliQ water, 1.25 ml of 0.5 
M Tris-HCl (pH 6.8), 0.65 ml of a 30% acrylamide solution, 100 µl of 10% (w/v) SDS, 50 µl 
of 10% ammonium persulphate (freshly prepared), and 10 µl of TEMED. Water and 
unpolymerised acrylamide were removed from the separating gel. The stacking gel was 
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poured on top of the polymerised separating gel. The comb was inserted and then the stacking 
gel was allowed to polymerise for at least 30 min. The comb was then carefully removed and 
the wells were rinsed with 1 × electrophoresis buffer (5 × buffer: 12.12 g of Tris base, 57.16 g 
of glycine, 4 g of SDS, 800 ml of MolliQ water, pH 8.3). The whole assembly was placed in 
an electrophoresis chamber, and the chamber was filled with 1 × electrophoresis buffer. 
Whole cell lysate was diluted 1:2 in sample buffer (1 ml of 0.5M Tris-HCl (pH 6.8), 2 ml of 
glycerol, 1.6 ml of 10% SDS (w/v), 0.2 ml of 0.5% bromophenol blue (w/v), 0.4 ml of 2-6-
mercaptoethanol, and 2.8 ml of MilliQ water), heated at 100˚C for 4 min, and loaded 
(appropriate volume) into wells in the gel. The SeeBlue
TM
 Plus2 Pre-Stain standard 
(Invitrogen) was used as the molecular weight marker. Electrophoresis was carried out at 100 
V until the tracking dyes reached the separating gel edge. After electrophoresis, the gel was 
removed and processed for further applications. 
Electrophoretic transfer 
Bacterial components that had been separated on the gel were electrically transferred onto 
nitrocellulose membrane. The separating gel was soaked in 1 × transfer buffer (12.12 g of Tris 
base, 57.60 g of glycine, 3,200 ml of MilliQ water, and 800 ml of methanol) to equilibrate for 
5 min. A piece of nitrocellulose membrane, eight pieces of 3M whatman paper (filter paper), 
and scotch brite pads were also soaked in transfer buffer for 5 min. The transfer cassette was 
made in the following order: 1 soaked scotch brite pad, 4 sheets of whatman 3M paper, 
polyacrylamide gel, membrane, 4 soaked sheets of filter paper, and scotch brite pad on the 
back section of the cassette. The cassette was closed and submerged in a trans-blot tank with 
the membrane on the anode side of the gel. The tank was filled with transfer buffer and the 
electrophoretic transfer was carried out at 70 V for 2 h. 
Immunoblotting with cholera toxin B subunit (CTB) 
The regions of nitrocellulose membrane surrounding the bound proteins or LOSs were 
blocked by incubation with blocking solution (3% BSA and 0.5% gelatin in 0.01M PBS, pH 
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7.4) for 1 h on a rotary shaker at room temperature. The blocking solution was removed and 
the membrane was washed for 3 times for 15 min (each) by gentle shaking in PBS-T (0.05% 
Tween-20 in 0.01M PBS, pH 7.4). The membrane was incubated with 25 ml of CTB solution 
[0.4 µg/ml CTB (Calbiochem) in dilution buffer (0.2% BSA and 0.2% gelatin in 0.01M PBS, 
pH 7.4)] at room temperature for 1 h with gentle shaking and the membrane was then washed 
3 times with excess volume of PBS-T as previously described. The membrane was placed in a 
solution of goat anti-CTB (1:10,000 in dilution buffer) for 1 h at room temperature with 
gentle shaking and washed as mentioned above. After washing, the membrane was placed in a 
solution of rabbit anti-goat HRP (diluted 1:3,000 in dilution buffer, Bio-Rad) for 1 h at room 
temperature with gentle shaking and washed as previously described. The membrane was 
incubated for 10 min in 50 ml of 1/15M phosphate buffer (pH 7.6). Finally, the membrane 
was placed in a plastic box containing a freshly prepared substrate solution (1 ml of 4-chloro-
1-naphthol in methanol (30 mg/ml), 10 ml of methanol, 49 ml of 1/15 PB, and 30 µl of H2O2) 
with gentle shaking until the red-brown bands appeared. The enzyme-substrate reaction was 
stopped by rinsing the membrane with distilled water and the membrane was air dried.  
Construction of the C. jejuni wlaVA mutant 
The mutated wlaVA construct was kindly provided by Dr. Viraj N. Perera (School of Applied 
Sciences, RMIT University, Australia). This construct consists of a pBluescript plasmid 
carrying the wlaVA gene of C. jejuni strain HB 93-13, which is inactivated by a kanamycin 
resistance cassette (Km). It was introduced into C. jejuni strains using natural transformation 
and/or electro-transformation. 
Natural transformation 
C. jejuni was transformed with DNA using natural transformation as previously described 
(108). C. jejuni was grown as previously mentioned. Bacterial cells were harvested in 1 ml of 
heart infusion broth. Bacterial suspension (50 µl) was transferred into a microcentrifuge tube 
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containing 1 ml of heart infusion agar. The lid was closed and pierced. The tube was 
incubated under microaerobic conditions at 37˚C for 3 h. After incubation, 10 µg of plasmid 
or chromosomal DNA was added and the mixture was incubated at 37˚C for another 3 h. The 
mixture containing cells and DNA was then transferred onto blood agar plates supplemented 
with appropriate antibiotics, and the plates were incubated under microaerobic conditions at 
37˚C for at least 2 days. 
Preparation of C. jejuni competent cells 
Competent cells were prepared by treating C. jejuni cells with SG solution containing 9% 
sucrose and 15% glycerol in MilliQ water. This solution was sterilized by filtration through a 
0.2-µm membrane. C. jejuni was grown as previously described. Bacterial cells were washed 
once with 1 ml of cold SG solution at 3,300 × g for 6 min at 4˚C. After centrifugation, the 
pellet was resuspended in 0.5 ml of cold SG solution, and 40 µl of bacterial suspension 
(competent cells) was aliquoted into microcentrifuge tubes and chilled on ice for immediate 
use or stored at -70˚C for long term storage.   
Introduction of DNA into competent C. jejuni by electrotransformation 
Competent cells (40 µl) were mixed with genomic DNA or plasmid DNA (0.1-1 µg) and the 
mixture was chilled on ice for 1 min. If the competent cells had been stored at -70˚C, they 
were first thawed on ice for 30 min before mixing with DNA. The entire mixture was 
transferred into a chilled electroporation cuvette (0.2 cm width, Bio-Rad). The Gene Pulser 
apparatus (Bio-Rad) was set at 25 µF, 2.48 kV, and 200 Ω. The mixture was pulsed once at 
these settings and the cuvette was immediately filled with 1 ml of SOC medium (91). The 
mixture was transferred to Mueller Hinton agar plates or blood agar plates without antibiotic 
supplements and incubated under microaerobic conditions at 37˚C overnight. Bacterial cells 
were harvested in 0.2 ml of heart infusion broth and grown on blood agar plates supplemented 
with appropriate antibiotics under microaerobic conditions at 37˚C for at least 2 days. 
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PCR-RFLP of the entire wlaII gene cluster 
Amplification of the entire wlaII gene cluster was carried out by using the Expand Long 
Template PCR system (Roche). All steps were performed on ice. Using the genome sequence 
of C. jejuni NCTC 11168 (81), the primer WaaC-F, which is located in the waaC gene (5'-
CCGTGGTTTTGCAATTTATC-3', nucleotide 53 to 72), and the primer WaaF-R, which is 
located in the waaF gene (5'-AAGTTCTTGTTCGGCTTTTC-3', nucleotide 594 to 575), were 
designed. The reaction mixture was prepared in a total volume of 50 µl containing 1 µl of 
DNA template (100 ng/µl), 5 µl of buffer 3, 1.75 µl of dNTP mix (10 mM each, Roche), 2 µl 
of primer WaaC-F (50 ng/µl), 2 µl of primer WaaF-R (50 ng/µl), 0.75 µl of enzyme mix, and 
37.5 µl of MilliQ water. The PCR conditions were programmed on a GeneAmp PCR system 
2400 (Perkin Elmer) as follows: 1 cycle of 94˚C for 2 min; 10 cycles of 94°C for 10 s, 47˚C 
for 30 s, 68˚C for 12 min; 20 cycles of 94˚C for 15 s, 47°C for 30 s, 68˚C for 12 min (add 20 s 
in each successive cycle); and 1 cycle of 68˚C for 7 min. After amplification, the PCR product 
was digested with 40 U of HindIII (Promega) at 37˚C overnight according to the 
manufacturer’s instruction. After digestion, 20 µl of digestion product mixed with 2 µl of 11 × 
loading buffer (91) was loaded on a 1.5% (w/v) agarose gel in 1 × TAE buffer (91). A 
standard marker of lambda DNA digested with PstI was used. Electrophoresis was conducted 
at 100 V for 90 min in 1 × TAE buffer. The gel was stained in ethidium bromide solution (6 
µg/ml) for 10 min, destained in running water for 40 min, and photographed using a gel 
documentation system (GelDoc, Bio-Rad).   
PCR-RFLP of the entire wlaI gene cluster 
Amplification of the entire wlaI gene cluster was carried out by using the Expand Long 
Template PCR system (Roche) as previously described in the PCR-RFLP of the wlaII gene 
cluster. Using the sequence data of the wlaI gene cluster of C. jejuni 81116 (25), the primer 
GalE1, which is located in the galE gene (5'-GCGGTGGTGCAGGTTATATAGG-3', 
nucleotide 17 to 38), and the primer WlaM, which is located in the wlaM gene (5'- 
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GCTCACTCCACCGATAAGAT-3', nucleotide 831 to 812), were designed and used for 
PCR. The PCR product was digested with 40 U of HhaI (Promega) at 37˚C overnight 
according to the manufacturer’s instruction. 
PCR-RFLP of the DNA fragment downstream of the waaF gene (waaF to Cj1152c)  
PCR was carried out using pfu polymerase (Roche). Using the genome sequence of C. jejuni 
NCTC 11168 (81), the primer WaaF-F, which is located in the waaF gene (5'-
TACATCTTCCCACCTGGTTA-3', nucleotide 14 to 33), and the primer Cj1155c-R, which is 
located in the Cj1155c gene (5'-ATGCTTGCACCATACCTTTG-3', nucleotide 116 to 97), 
were designed and used for PCR. The reaction mixture was prepared in a 50 µl total volume 
of 1 × pfu buffer containing 200 µM of each dATP, dTTP, dCTP, dGTP, 100 ng of primer 
WaaF-F, 100 ng of primer Cj1155c-R, 100 ng of DNA template, and 5 U of pfu polymerase. 
The PCR conditions were as follows: 94˚C for 1 min (initial denaturation); 35 cycles of 94˚C 
for 30 s, 47˚C for 1 min, 72˚C for 11 min; 72˚C for 3 min (final elongation). The PCR product 
was digested with 30 U of HindIII (Promega) at 37˚C overnight according to the 
manufacturer’s instruction. 
PCR-RFLP of the DNA fragment downstream of the Cj1152c gene (Cj1152c to dnaX) 
PCR was carried out using pfu polymerase (Roche) as previously described, except that the 
annealing temperature was 60˚C. Using the genome sequence of C. jejuni NCTC 11168 (81), 
the primer Cj1155c-F, which is located in the Cj1155c gene (5'-
AGGTATGGTGCAAGCATTAT-3', nucleotide 100 to 119), and the primer DnaX-R, which 
is located in the dnaX gene (5'-TAGGCTCTCCAAAACAATCT-3', nucleotide 1516 to 1497), 
were designed and used for PCR. The PCR product was digested with 30 U of HindIII 
(Promega) at 37˚C overnight according to the manufacturer’s instruction. 
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Pulse-field gel electrophoresis (PFGE) 
C. jejuni was grown as previously described. Bacterial cells were washed once with 1 ml of 
PBS at 3,300 × g for 6 min and then resuspended in 800 µl of PIV buffer (10 mM Tris-HCl, 
1M NaCl, pH 7.6). Four hundred microliters of bacterial suspension (OD600 of 0.57-0.82) was 
gently mixed with 400 µl of melted low melting agarose (2% agarose in PIV buffer). The 
mixture was dispensed into wells of reusable plug molds and allowed to solidify at room 
temperature for at least 30 min. The plugs were transferred into plastic tubes (10 ml in size) 
containing lysis buffer [0.5 M EDTA (pH 9.0), 1% sarcosine, 1 mg/ml proteinase K] and the 
tubes were then incubated at 50°C with gentle shaking overnight. After incubation, lysis 
buffer was substituted by 2 ml of PMSF solution and the tube was then incubated at 37˚C for 
1 h with gentle shaking to inactivate proteinase K. Inactivation of proteinase K was repeated 
once. PMSF solution was prepared by mixing 1 ml of 18.6 mg/ml PMSF in isopropanol 
(completely dissolved) with 25 ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and 
the mixture was incubated at 37˚C for 15 min.  After inactivation of proteinase K, the PMSF 
solution was substituted by TE buffer and the tubes were incubated at room temperature for 
30 min with gentle shaking. This step was repeated twice. The plugs were added to fresh TE 
buffer and stored at 4°C. The plugs were cut into small pieces (1 mm width) and the intact 
chromosomal DNA embedded inside the agarose was digested with 30 U of SacII at 37˚C 
overnight according to the manufacturer’s instructions. The plugs were washed once with TE 
buffer and stored in 0.5 × TBE buffer at 4˚C. Digested DNA fragments were separated on a 
1.4% agarose gel (molecular agarose grade) at 14˚C in 0.5 × TBE buffer using the LKB gene 
navigator (Pharmacia). The PFGE conditions were as follows: pulse time between 0.5 s to 20 
s (interpolation) and run time for 23 h.  
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LOS isolation 
C. jejuni was grown at 37˚C for 2 days under microaerobic conditions as previously 
described. Bacterial cells were harvested from 2 plates and washed once with 5 ml of PBS at 
5,445 × g (5,500 rpm) for 10 min. The pellet was resuspended in 2 ml of solution I (50 mM 
Tris-HCl, 2 mM EDTA, pH 8.5). Bacterial cells were homogenised on ice at 70% amplitude 
for 3 times for 30 s (each) with 20 s intervals using a Branson Digital Sonifier. Homogenised 
samples were centrifuged at 1,312 × g (2,700 rpm) for 20 min. The supernatants (1.5 ml) were 
transferred into microcentrifuge tubes and centrifuged at 16,100 × g (13,200 rpm) at 4˚C for 1 
h. After the supernatants were discarded, 100 µl of solution II (2 mM Tris-HCl, pH 7.8) and 
300 µl of Laemmli sample mix [2.5 ml of 0.5 M Tris-HCL (pH 6.8), 4 ml of 10% SDS, 2 ml 
of 100% glycerol, 1 ml of β-mercaptoethanol, 2 ml of 0.02% bromophenol blue, and 3.5 ml of 
water] were added to the pellets. The mixture was boiled for 15 min, and after 20 µl of 
proteinase K (1 mg/ml) was added, it was incubated at 56˚C for at least 1 h. 
Separation of LOS components using Tricine-SDS-PAGE 
LOS components were separated on maxi-gels. The assembly of the sandwich glass plates 
was performed as described in the instruction manual (Bio-Rad). The separating gel was 
prepared by mixing the following: 5.7 ml of MilliQ water, 3.9 ml of glycerol, 12.37 ml of gel 
buffer (3 M Tris base, 0.3% SDS, pH 8.45), 15.45 ml of 40% acrylamide stock. The mixture 
was gently mixed and polymerisation was initiated by adding 300 µl of 10% ammonium 
persulfate in MilliQ water (freshly prepared) and 30 µl of TEMED. The gel was poured gently 
into the space between the two glass plates to the level of 3-4 cm below the upper edges of the 
plates. The gel was overlaid with MilliQ water and allowed to polymerise for 2 h. The 
stacking gel was prepared by mixing the following: 5.55 ml of MilliQ water, 2.25 ml of gel 
buffer, and 1.2 ml of 40% acrylamide stock. The gel polymerisation was initiated by adding 
75 µl of 10% ammonium persulfate and 7.5 µl of TEMED. The stacking gel was poured on 
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top of the polymerised separating gel. The comb was inserted and the stacking gel was left to 
polymerise for 1 h. The comb was then carefully removed and the wells were rinsed and 
cleaned with cathode buffer (0.1M Tris base, 0.1 M Tricine, 0.1% SDS, pH 8.25). The whole 
assembly was placed in an electrophoresis chamber. The chamber was filled with 300 ml of 
cathode buffer (inside) and 2000 ml of anode buffer (outside) (0.2 M Tris base, pH 8.9). The 
LOS samples (10-50 µl) were loaded into the wells in the gel. The SeeBlue
TM
 Plus2 Pre-Stain 
standard (Invitrogen) was used as the molecular weight marker. Electrophoresis was carried 
out at 130 V at 4˚C for 18 h or until the tracking dyes reached the bottom edge of the 
separating gel. After electrophoresis, the gel was removed and prepared for silver staining. 
Silver staining of LOS components separated using Tricine-SDS-PAGE 
All steps were performed at room temperature. The gel containing LOS components was 
fixed in fixing solution (40 % ethanol, 5 % acetic acid) overnight. The gel was then oxidised 
in oxidising solution (0.7 % periodic acid, 40 % ethanol, and 5 % acetic acid) for 5 min. The 
oxidised gel was washed with distilled water for 3 times for 15 min (each). After the water 
was drained from the gel, the freshly prepared silver staining reagent (28 ml of 0.1 M NaOH, 
2 ml of NH4OH, 5 ml of 20% AgNO3, and 115 ml of MilliQ water) was added and the gel 
was incubated for 10 min with gentle shaking. The stained gel was washed with distilled 
water for 3 times for 15 min (each). The colour was developed by placing the stained gel in a 
container containing formaldehyde solution (50 mg of citric acid, 0.5 ml of 37% 
formaldehyde, and 1,000 ml of distilled water) for 10-30 min. The colour development was 
stopped by transferring the gel to a container containing stop solution (10 g of Tris base, 5 ml 
of 80% acetic acid, 185 ml of distilled water). The stained gels were stored in 1% glycerol in 
MilliQ water.  
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RESULTS AND DISCUSSION 
Acquisition of a GM1-positive phenotype by WT 81116 
In this study, we hypothesised that a non-GM1 strain could take up LOS synthesis genes in 
vitro and potentially become a GBS-inducible strain. To test this hypothesis, C. jejuni strain 
81116 (Penner serotype O:6, named WT 81116), which was originally isolated from a human 
waterborne outbreak of gastroenteritis (78), was selected as the host cell in a natural 
transformation experiment. The LOS of this strain does not react with the CTB, which is 
GM1-specific. C. jejuni Penner serotype O:4 (named WT O:4) was selected as the donor cell 
because (i) it strongly reacted with CTB using Western blot analysis, (ii) the C. jejuni O:4 
wlaVA mutant (named O:4 ∆wlaVA) could be successfully constructed by introducing the 
selection marker for kanamycin resistance and still reacted with CTB, and (iii) mutating the 
wlaVA gene in a strain HB 93-13 (O:19) did not affect the LOS structure, the LOS sugar 
composition, and the ganglioside mimicry (Viraj N. Perera, unpublished data). C. jejuni 
81116 was transformed with chromosomal DNA of O:4 ∆wlaVA using natural transformation. 
Transformants were screened on selective medium supplemented with kanamycin. The 
transformation efficiency of WT 81116 was approximately 2 × 10
2
 CFU per 10 µg of 
genomic DNA. One hundred and fifty kanamycin resistant colonies were randomly picked 
and immunologically probed with CTB to screen for GM1-positive transformants. 
Surprisingly, 145 of the 150 colonies reacted with CTB while only 5 colonies were CTB-
negative (Fig. 1.1, selected transformants). Therefore, these results showed that C. jejuni 
81116 could be transformed into a number of potential GBS-inducible transformants. 
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Figure 1.1. Dot blot ELISA probed with CTB. 1, WT O:4; 2, O:4 ∆wlaVA; 3, WT 81116. A, 
L, M, O, and Q are all CTB-negative transformants. B and C are representative CTB-positive 
transformants. +, CTB positive; −, CTB negative.       
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Genetic exchange of the wlaII-LOS synthesis gene cluster 
To identify which O:4 ∆wlaVA genes had been acquired by the CTB-positive transformants, 
PCR-restriction fragment length polymorphism (PCR-RFLP) with HindIII as the restriction 
enzyme was performed. The primers WaaC-F and WaaF-R were used to amplify the entire 
wlaII gene cluster of WT O:4 (13.558 kb), O:4 ∆wlaVA (14.055 kb), WT 81116 (16.308 kb), 
13 selected CTB-positive transformants (B, C, D, E, F, G, H, I, J, K, N, P, and R), and all 5 
CTB-negative transformants (A, L, M, O, and Q) by PCR. For the CTB-positive 
transformants, the entire wlaII gene cluster (16.308 kb) was replaced by the wlaII locus of O:4 
∆wlaVA (14.095 kb) as the PCR-RFLP patterns of these transformants were identical to the 
pattern of O:4 ∆wlaVA and markedly different from that of WT 81116. For the CTB-negative 
transformants L, M, O, and Q, a partial exchange of LOS synthesis genes was observed. 
Presumably, some essential gene(s) for the synthesis of the GM1-like LOS and, hence, CTB 
binding is missing from their wlaII gene clusters. Surprisingly, CTB-negative transformant A 
had received the complete wlaII locus of O:4 ∆wlaVA (Fig. 1.2, also see Fig. 1.1). A possible 
explanation could be a change in the length of some of the homopolymeric tracts found in this 
gene cluster or mutations in the LOS synthesis genes (62) or other genes that are essential in 
the expression of the CTB-binding epitope. These results showed that part and even the entire 
wlaII gene cluster was easily taken up and integrated in the genome of C. jejuni 81116, 
resulting in new strains carrying GM1-like LOS structures.  
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Figure 1.2. PCR-RFLP patterns of the wlaII gene cluster digested with HindIII. λ, λ-DNA 
digested with PstІ; 1, WT O:4; 2, WT 81116; 3, O:4 ∆wlaVA; and A to R, transformants.   
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Identification of the integration point upstream of the waaC gene 
To identify the integration point upstream of the waaC gene, HhaI-PCR-RFLP was 
performed. The primers GalE1 and WlaM were used to amplify the wlaI gene cluster of WT 
81116 (14.061 kb), 81116 transformants (A to J), WT O:4, and O:4 ∆wlaVA. The PCR 
products of approximately 14 kb were obtained for all strains. PCR-RFLP patterns of 
transformants showed a high degree of variation within the wlaI gene clusters, and those were 
different from the patterns of WT 81116 and O:4 ∆wlaVA (Fig. 1.3). Restriction mapping 
analysis showed that WT 81116 had randomly integrated DNA fragments from the O:4 
∆wlaVA into its genome using various integration points. Most of them were positioned in the 
region of the galE gene as a 698-bp DNA fragment containing the partial galE gene was 
missing from the wlaI loci of transformants A, B, C, D, F, H, I, and J. A previous study in a 
C. jejuni strain GB11 also evidenced the integration point in the galE region (30). Other sites 
were distributed throughout the wlaI gene cluster such as in the wlaK, wlaF, wlaE, and wlaC 
genes. 
Identification of the integration point downstream of the waaF gene 
To identify the integration point downstream of the waaF gene, HindIII-PCR-RFLP was 
performed. The primers WaaF-F and Cj1155c-R were used to amplify a 5.1-kb DNA 
fragment ranging from the waaF gene to the Cj1155c gene by PCR. A PCR product of 
approximately 7 kb was obtained for the WT 81116, while a 5.1-kb PCR product was 
obtained for WT O:4, O:4 ∆wlaVA, and transformants B, C, D, E, F, G, H, and J. A PCR 
product could not be amplified from transformants A and I. RFLP analysis of the PCR 
products showed that all transformants tested had the pattern of the donor DNA, and the sites 
of recombination appeared to be located in or downstream of the Cj1155c gene. 
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Figure 1.3. PCR-RFLP patterns of the wlaI gene cluster digested with HhaI. λ, λ-DNA 
digested with PstІ; 1, WT O:4; 2, WT 81116; 3, O:4 ∆wlaVA; and A to J, transformants.   
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Identification of the integration point downstream of the Cj1152c gene 
To identify the integration point downstream of the Cj1155c gene, HindIII-PCR-RFLP was 
performed. The primers Cj1155c-F and DnaX-R were used to amplify a 5.2-kb DNA 
fragment ranging from the Cj1155c gene to the dnaX gene by PCR resulting in amplification 
products of approximately 5.2 kb for WT O:4, O:4 ∆wlaVA, WT 81116, and 81116 
transformants (B to J). A PCR product could not be amplified from transformant A. The 
integration point for transformants B, D, E, F, and H was located in or downstream of the 
dnaX gene since their RFLP patterns were identical to the RFLP pattern of O:4 ∆wlaVA. For 
transformants C, G, I, and J, the integration point was located in the Cj1155c gene as their 
RFLP patterns were identical to the pattern of WT 81116. The most upstream and 
downstream integration points for each 81116 transformant and the approximate sizes of WT 
81116 DNA that were deleted during genetic recombination are conclusively shown in   
Figure 1.4.  
Genotyping of 81116 transformants 
To determine whether natural transformation with chromosomal DNA resulted in new 
genotypes of C. jejuni, pulsed-field gel electrophoresis (PFGE) with SacII as the restriction 
enzyme was performed. The results showed that the SacII-PFGE patterns of the transformants 
A, B, C, D, E, F, H, I, and J were identical to the PFGE pattern of WT 81116 (Fig. 1.5, see 
representative PFGE pattern of transformant A). Interestingly, the PFGE pattern of the 
transformant G was different from that of WT 81116. A large 388-kb DNA fragment and a 
135-kb fragment of the O:4 ∆wlaVA were inserted into the chromosomal DNA of WT 81116. 
Presumably, this insertion is at a location other than the LOS gene cluster since the change 
involving the LOS genes is too small to be detected by PFGE. This indicated that not only the 
LOS gene cluster but also other locations throughout the WT 81116 genome had undergone a 
genetic exchange. These results showed that natural transformation can result in genotypic 
diversity, as also shown by previous studies (1, 11, 109).  
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Figure 1.4. The wlaI locus (wlaM-Cj1132c), the wlaII locus (waaC-waaF) and its 
downstream region (waaF-dnaX), approximate DNA fragment sizes that were deleted from 
WT 81116 (numbers within parentheses), and integration points (arrows). WT 81116, host 
cell (GM1, accession no. Y11648, AF343914, and AJ131360, also see Figure 3 in the general 
introduction); O:4, donor cell (GM1
+
, accession no. AF215659, also see Figure 3 in the 
general introduction); A to J, 81116 transformants exhibiting ganglioside GM1 (except 
transformant A); boldface letters, homologous gene regions; 
a
, essential genes for the 
formation of ganglioside-like LOS structures; dash between genes, unknown DNA regions; 
vertical arrows, the most upstream and downstream integration points; triangle point (left), 
integration point in or upstream of wlaM; elbow arrows and triangle points (right), integration 
points in or downstream of waaF and dnaX, respectively; N, not determined as no PCR 
product was obtained; *, integration point for kanamycin resistance cassette in O:4 ∆wlaVA. 
w
la
M
  
w
la
L
 
w
la
K
 
w
la
I 
 
w
la
H
 
w
la
G
 
w
la
F
 
w
la
E
 
w
la
D
  
w
la
C
 
w
la
B
 
g
al
E
 
C
j1
1
3
2
c 
w
a
a
C
 
h
tr
B
 
o
rf
3
 
o
rf
2
1
 
o
rf
2
2
 
o
rf
2
3
 
o
rf
2
4
 
o
rf
2
5
 
o
rf
2
6
 
o
rf
2
7
 
o
rf
2
8
 
o
rf
2
9
 
o
rf
3
0
 
o
rf
3
1
 
o
rf
3
2
 
o
rf
3
3
 
o
rf
3
4
 
w
a
a
V
 
w
a
a
F
ª 
  
  
C
j1
1
5
5
c 
  
 
d
n
aX
 
WT 81116 
 
A (19 kb) 
 
B (45 kb) 
 
C (32 kb) 
 
D (37 kb) 
 
E (37 kb) 
F (36 kb) 
 
G (36 kb) 
 
H (41 kb) 
 
I (24 kb) 
 
J (36 kb) 
 
O:4 ∆wlaVA
 
N
 
w
a
a
C
h
tr
B
w
la
N
C
ªw
la
N
D
ªc
g
tA
ªc
g
tB
ªc
st
II
ªn
eu
B
ªn
eu
C
ªn
eu
A
*
w
la
V
A
w
a
a
V
ªw
a
a
F
N
Unknown sequence Unknown sequence 
 41
 
 
 
 
 
Figure 1.5. SacII-PFGE patterns of the transformants. λ, molecular size marker (48.5-kb 
lambda concatemer); 1, WT 81116; 2, O:4 ∆wlaVA; A and G, transformants. Arrows indicate 
two DNA fragments of O:4 ∆wlaVA found in the transformant G. 
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LOS analysis of 81116 transformants 
To examine the LOS molecules of transformants A to J, L, M, O, and Q, LOS was isolated 
and separated by Tricine-SDS-PAGE, followed by silver staining. The LOS patterns of all 
transformants were different from the LOS patterns of both WT 81116 and O:4 ∆wlaVA, 
except for LOS isolated from transformant Q that showed a similar LOS pattern to the WT 
81116. Interestingly, the CTB-positive transformants (B, C, D, E, F, G, H, I, and J) carrying 
the LOS gene cluster of O:4 ∆wlaVA
  
showed a different LOS pattern to that of O:4 ∆wlaVA. 
The cause for this difference is unclear and requires further investigation. As expected, the 
LOS patterns of WT O:4 and O:4 ∆wlaVA were similar (Fig. 1.6). These results indicated that 
not only the wlaII gene cluster but also other genes seem to be involved in LOS synthesis.  
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Figure 1.6. LOS analysis by Tricine-SDS-PAGE followed by silver staining. 1, WT O:4; 2, 
O:4 ∆wlaVA; 3, WT 81116; A to Q, transformants exhibiting CTB-positive (+) or -negative 
(−) phenotypes.  
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CONCLUSION 
This study showed that a non-GM1 C. jejuni strain can take up DNA in vitro and transform 
into a number of potential GBS-inducing strains. Furthermore, we have shown that horizontal 
gene transfer between C. jejuni strains can result in genome plasticity. This result directly 
limits the current typing systems and complicates epidemiological studies. Moreover, since 
the incidence of mixed infections in areas of endemicity is high and could lead to the 
acquisition of virulence genes by non-pathogenic strains via interstrain genetic exchange, this 
result also indicates potential risks in using C. jejuni as a live vaccine in both animals and 
humans.  
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CHAPTER II 
Evaluation of current RNA isolation methods for transcriptional analysis of the 
wlaII-LOS synthesis gene cluster from C. jejuni strains 
 
 
 
 
 
 
 
The study described in this chapter was accepted for publication in 
Journal of Microbiological Methods, in press 
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ABSTRACT 
DNA-free RNA samples are essential to investigate gene regulation using real-time RT-PCR. 
While attempting to analyse transcription of the lipooligosaccharide (LOS) synthesis gene 
cluster using RT-PCR, it was found that none of the published methods nor commercially 
available kits for RNA isolation could produce DNA-free RNA from Campylobacter jejuni 
strain HB 93-13. This study evaluated eight RNA isolation methods, including RNAzol B, 
Trizol, RNAgent, RNAwiz, RNeasy with DNase column, hot/SDS phenol RNA prep, and 
Triton X-100-based mRNA rich isolation and its modifications, for transcriptional analysis of 
the LOS-synthesis neuC gene from C. jejuni strain HB 93-13. RNA isolations were performed 
according to the published protocols and the manufacturers’ instructions. Contaminating DNA 
was removed from RNA using a combination of TURBO DNase treatment and acid phenol 
extractions. Purified RNA samples were evaluated for purity and quantity using a 
spectrophotometer, quality by formaldehyde gel electrophoresis, and the presence of DNA by 
PCR and real time RT-PCR. The results showed that all methods yielded RNA with high 
purity levels. The highest RNA quantity was obtained with the Trizol and hot/SDS phenol 
RNA prep-based methods. The RNeasy with DNase column, Trizol, RNAwiz, and RNAzol 
B-based methods showed a high RNA quality. A DNA-free RNA sample could only be 
obtained using the RNAzolB-based method. The RNAgent, Trizol, and RNAwiz-based 
methods produced an RNA sample slightly contaminated with DNA, and the remaining 
methods showed high levels of DNA contamination. This study showed that a DNA-free 
RNA sample could be obtained for C. jejuni HB 93-13 by using RNAzolB in combination 
with TURBO DNase treatment and acid phenol extractions.  
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INTRODUCTION 
Most researchers use either acid phenol extraction or DNase treatment to remove DNA from 
RNA samples. DNA decontamination is a crucial step for RNA preparation particularly when 
RNA samples are used for the investigation of gene regulation using real-time RT-PCR. 
When using acid phenol (pH 4-6) to remove DNA, DNA is retained in the organic phase and 
the interface, leaving the RNA in the aqueous phase (15). DNase is a non-specific 
endonuclease that degrades double-and single-stranded DNA. Presently, conventional DNase 
I and its variant, TURBO DNase, which has a greater catalytic efficiency than DNase I 
(Ambion), are widely used for DNA decontamination.  
The efficiency of the removal of DNA from an RNA sample depends on the particular 
bacterial strain from which it is isolated. In a previous study DNA could be completely 
eliminated using DNase alone from an RNA sample isolated from Escherichia coli DH5α. In 
contrast, an RNA sample obtained from the Guillain-Barré syndrome-inducing 
Campylobacter jejuni strain HB 93-13 (40) still contained contaminating DNA after repeated 
treatment with DNase followed by acid phenol extraction. The aim of this study was to 
compare RNA isolation methods for their ability to produce DNA-free RNA, which could be 
used with real-time RT-PCR for transcriptional analysis of the lipooligosaccharide (LOS) 
synthesis gene cluster from C. jejuni strain HB 93-13. 
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MATERIALS AND METHODS 
RNA isolation 
C. jejuni strains 81116 (78), HB 93-13 (40), ATCC 43446, O:41, O:36, OH 4382 (3), 11168, 
PEN 4, and O:4 (a variant strain of PEN 4) were included in this study. Bacteria were grown 
on Columbia agar plates supplemented with 5% defribinated horse blood under microaerobic 
conditions (5% O2, 10% CO2, and 85% N2) at 42˚C for 16 h. The bacterial cells were 
harvested in cold PBS and washed once by centrifugation at 3,300 × g at 4˚C for 6 min. RNA 
was isolated using RNAzol B (Tel-Test), Trizol (Invitrogen), RNAgent (Promega), RNAwiz 
(Ambion), RNeasy with DNase column (Qiagen), Triton X-100-based mRNA-rich RNA 
isolation (99), and hot/SDS phenol RNA prep 
(http://www.bio.davidson.edu/projects/GCAT/protocols/ecoli/RNApurification.pdf) according 
to the published protocols or the manufacturers’ instructions. In addition, a modified Triton 
X-100-based method was used in which acid phenol extraction (125:24:1, pH 4.5, Ambion) 
was used instead of a chloroform extraction. 
RNA purification and analysis 
RNA samples were treated with 10 U of TURBO DNase (Ambion) in a total volume of 700 µl 
at 37˚C for 2 h. After DNase treatment, the mixture was added with 700 µl of acid phenol 
(125:24:1, pH 4.5, Ambion), shaken vigorously for 20 s, incubated at room temperature for 15 
min, and centrifuged at 16,100 × g at 4˚C for 15 min. The upper phase containing RNA was 
transferred into a new tube. The RNA was then precipitated by addition of 0.1 volume of 3 M 
sodium acetate (pH 5.2), 2.5 volumes of absolute ethanol, and incubation at -20˚C for 30 min. 
After centrifugation, the RNA pellet was washed once in 1 ml of 70% cold ethanol and 
centrifuged at 16,100 × g for 5 min. The RNA pellet was air-dried for 15 min and 
reconstituted with 100 µl of RNase-free water. The quantity of the purified RNA samples was 
determined by measuring the absorbance at 260 nm (A260) using a spectrophotometer (Cary 
50, Varian), the purity by measuring the A260/A280 ratio, the quality by separating RNA 
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samples on a 2% formaldehyde gel as described in the RNeasy handbook, and the presence of 
contaminating DNA by PCR. 
Reverse transcription 
The cDNA synthesis was performed using the Omiscript reverse transcriptase kit (Qiagen). 
One microgram of RNA in a total volume of 13 µl was heated at 70°C for 3 min and 
immediately chilled on ice. The reaction mixture was prepared in a total volume of 20 µl, 
which consisted of 1 × RT buffer, 1 µg of heated RNA, 10 U of rRNasin (Promega), 50 ng of 
primer NeuC-R (5'-CCTTGAGCCAACTAAAATTC-3', nucleotide 8865-8884c, accession 
no. AY297047), 10 U of reverse transcriptase, and 500 µM of each dATP, dTTP, dCTP, 
dGTP. Reverse transcriptase was substituted by RNase-free water for the negative control. 
The RNA sample was substituted by genomic DNA isolated from C. jejuni HB 93-13 and 
used as the positive control. The reaction mixture was incubated at 37°C for 1 h and heated at 
94˚C for 2 min. Ten µl of RNase A solution (50 µg/ml) was then added and the sample was 
incubated at 37˚C for 20 min.  
Polymerase chain reaction 
Two types of PCR were performed. The first of these was a general PCR and was carried out 
on a GeneAmp PCR system 2400 (Perkin Elmer) using Taq polymerase (ABI). The reaction 
mixture was prepared in a total volume of 50 µl, which contained 1 × Taq buffer, 1.5 mM of 
MgCl2, 200 µM of each dATP, dTTP, dCTP, dGTP, 50 ng of each primer (NeuC-R as 
previously described and NeuC-F, 5'-GCCACGCTATATCAAAACTA-3', nucleotide 8379-
8398, accession no. AY297047), 4 µl of reverse transcription product, and 2.5 U of Taq 
polymerase. PCR conditions were as follows: 94˚C for 3 min; 35 cycles of 94˚C for 30 s, 
55˚C for 1 min, 72˚C for 1 min; and 72˚C for 7 min. The second type PCR was a quantitative 
PCR, which was performed on the MyiQ (Bio-Rad) using iQ SYBR Green Supermix (Bio-
Rad) according to the manufacturer’s instructions. PCR conditions were as follows: cycle 1 (1 
 50
×): 95˚C for 5 min; cycle 2 (35 ×): 95˚C for 30 s, 55˚C for 30 s, 72˚C for 30 s; cycle 3 (100 
×): 95˚C for 10 s (decrease setpoint temperature after cycle 2 by 0.5˚C, and enable melt curve 
data collection and analysis).  
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RESULTS AND DISCUSSION 
Comparison of purity, quantity, and quality of RNA samples 
To enable the purification of good quality DNA-free RNA from C. jejuni to study 
transcription, the RNeasy with DNase column, RNAgent, RNAwiz, RNAzolB, Trizol, 
Hot/SDS phenol RNA prep, and Triton X-100-based mRNA-rich RNA isolation and its 
modification in combination with TURBO DNase treatment and acid phenol extraction 
methods were compared for RNA purity, quantity, and quality. The results showed that all 
methods showed a high RNA purity as their A260/A280 ratios were close to 1.8 (Table 2.1). 
Both the Trizol-based method and the hot/SDS phenol RNA prep-based method showed the 
highest RNA quantity (1.1 µg/µl), while the RNA yields for the other methods were close to 
0.7 µg/µl (Table 2.1). A high RNA quality was obtained from the RNeasy with DNase 
column, RNAwiz, RNAzol B, and Trizol-based methods as these samples showed clear 
patterns on a formaldehyde gel. Interestingly, two patterns of total RNA were observed for 
different C. jejuni strains. The RNA pattern of strains 81116, PEN 4, and O:4 exhibited a 
normal pattern showing three separate bands, corresponding to 23S rRNA, 16S rRNA, and 5S 
rRNA as found in other Gram-negative bacteria (see RNeasy handbook). In contrast, the RNA 
pattern of strains HB 93-13, OH 4382, ATCC 43446, NCTC 11168, O:36, and O:41 revealed 
four bands (Fig. 2.1, selected result). It seems likely that the 23S rRNA fragment is cleaved 
resulting in two molecules, one larger and one smaller than 16S rRNA. 
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Table 2.1. Comparison of quantity and purity of RNA samples isolated by different methods                                                  
RNA isolation method Total RNA (µg/µl) A260/A280 
Qiagen with DNase column  
Hot/SDS phenol RNA prep  
Triton X-100-based method  
Modified Triton X-100 method  
RNAgent  
RNAwiz  
RNAzol  
Trizol  
0.76 
1.09 
0.56 
0.63 
0.69 
0.74 
0.71 
1.06 
1.78 
1.77 
1.79 
1.76 
1.76 
1.79 
1.76 
1.98 
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Figure 2.1. Comparison of RNA quality after separation on a 2% formaldehyde gel. M, RNA 
molecular weight marker (0.5-9 kb). 1-8, RNA samples isolated from C. jejuni HB 93-13 
using different methods (1-8) in combination with TURBO DNase treatment and acid phenol 
extraction. 1, RNeasy with DNase column; 2, hot/SDS phenol RNA prep; 3, Triton X-100-
based mRNA-rich RNA isolation; 4, modified triton X-100-based mRNA-rich RNA isolation; 
5, RNAgent; 6, RNAwiz; 7, RNAzol B; and 8, Trizol. A-F show two forms of total RNA 
patterns among C. jejuni strains. A, ATCC 43446; B, NCTC 11168; C, NCTC 81116; D, 
O:36; E, O:41; and F, PEN 4. RNA samples (A-F) were isolated using the RNAzol B-based 
method. Arrows indicate the 5S, 16S, and 23S rRNA subunits. 
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Detection of contaminating DNA in RNA samples 
Transcription of the neuC gene of C. jejuni HB 93-13 was analysed under normal growth 
conditions using RT-PCR and/or real-time RT-PCR. For RT-PCR, as expected, the neuC-
specific cDNA fragments of approximately 500 bp were detected from all RNA samples 
isolated using the different RNA isolation methods. For the RNAzol B-based method, no RT-
PCR product was obtained for the negative control without reverse transcriptase, showing the 
lack of DNA contamination in the RNA sample. However, for all other methods, the neuC- 
specific DNA fragments were detected in all negative controls, showing DNA contamination 
in these RNA samples (Fig. 2.2A). Similarly, the results of real time RT-PCR showed that 
only the RNAzol B-based method could produce DNA-free RNA, while the other methods 
showed high DNA contamination in RNA samples (result not shown). It was noted that after 
the amount of PCR template (reverse transcription product) was reduced from 4 µl to 1 µl, no 
PCR product was observed from the negative controls of the RNAgent, RNAwiz, and Trizol-
based methods, showing that these methods produced RNA samples that were slightly 
contaminated with genomic DNA (result not shown). This is in contrast to the Qiagen with 
DNase column, Hot/SDS phenol RNA prep, Triton X-100-based mRNA-rich RNA isolation 
and its modification methods, which still showed high DNA contamination in the RNA 
samples (Fig. 2.2B). These results showed that DNA-free RNA samples could only be 
achieved using the RNAzol B-based method. 
Strain specificity of DNA decontamination 
To examine whether the severity of DNA contamination is strain-specific, C. jejuni strains 
HB 93-13, NCTC 11168, ATCC 43446, OH 4382, O:36, O:4, PEN 4, and O:41 were used to 
isolate RNA. The RNAzol B kit was used to prepare RNA samples of which some were 
exposed to both acid phenol extraction and TURBO DNase treatment to remove any 
remaining DNA. After DNA decontamination, all samples were treated with the RNase A 
enzyme as previously described. PCR was performed to amplify a fragment of the neuC gene 
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from these samples. The DNA sample isolated from C. jejuni strain 81116 without the neuC 
gene in its LOS synthesis gene cluster (accession no. Y11648 and AF343914) was used as the 
internal negative control. A DNA sample isolated from C. jejuni strain HB 93-13 was used as 
the positive control. No PCR product was observed using the RNase and DNase-treated RNA 
samples, while PCR products of 506 bp were detected from the RNase-treated RNA samples. 
As expected, a 500 bp PCR product was detected for the positive control, and no PCR product 
was observed for the internal negative control (Fig. 2.2C). These results showed that DNA 
decontamination was essential for all C. jejuni strains tested as all RNA samples contained 
DNA. 
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Figure 2.2. RT-PCR results. A, Detection of DNA contamination in RNA samples isolated by 
different methods (1-8) in combination with DNA decontamination methods (TURBO DNase 
treatment and acid phenol extraction). 1, RNeasy with DNase column; 2, hot/SDS phenol 
RNA prep; 3, Triton X-100-based mRNA-rich RNA isolation; 4, modified Triton X-100-
based mRNA-rich RNA isolation; 5, RNAgent; 6, RNAwiz; 7, RNAzol B; and 8, Trizol. Plus 
(+), RT-PCR products of neuC-specific cDNA fragment (506 bp). Minus (-), RT-PCR 
products from the negative controls without reverse transcriptase, showing DNA 
contamination in RNA samples. B, comparison of the amount of contaminating DNA in the 
negative controls (1-4, as described in A) using quantitative real-time RT-PCR. C, Detection 
of DNA in RNA samples isolated from various C. jejuni strains using PCR. Arrows: neuC-
specific PCR products (506 bp) in different C. jejuni strains. X, RNase-treated RNA sample; 
Y, RNase and DNase-treated RNA sample. 
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CONCLUSION 
This study showed that most RNA isolation methods could not isolate RNA without DNA 
from C. jejuni strains. DNA-free RNA samples could only be isolated from C. jejuni using the 
combination of RNAzol B, TURBO DNase treatment, and acid phenol extraction. This 
difficulty might be caused by species-specific DNA conformation or chromatin structure. For 
example, very tight DNA packaging may render it insensitive to denaturation and separation. 
Moreover, two types of rRNA subunits were observed for different C. jejuni strains. Future 
investigations might reveal if these different types result in changes in protein synthesis or 
have some evolutionary advantage.  
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CHAPTER III 
Transcription analysis of the wlaII-LOS synthesis gene cluster from the GBS-
inducing C. jejuni strain HB 93-13 
 
 
 
 
 
 
 
The study described in this chapter was submitted for publication 
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ABSTRACT 
The lipooligosaccharide (LOS) molecules of Campylobacter jejuni are involved in virulence 
and induction of the Guillain-Barré syndrome (GBS). This study analysed transcription of the 
LOS synthesis genes from the GBS-inducing C. jejuni strain HB 93-13 under microaerobic 
conditions. Fourteen consecutive genes Cj1132c, waaC, htrB, wlaNC, wlaND, cgtA, cgtB, 
cstII, neuB, neuC, neuA, wlaVA, wlaQA, and waaF were included. The results of rapid 
amplification of cDNA ends and single-stranded ligation of complementary ends showed 
initiation sites with potential promoter regions on both DNA strands in the Cj1132c/waaC, 
cgtB/cstII, and wlaQA/waaF strand-switch regions. Other termini without recognisable 
promoter region were also found throughout the LOS gene cluster, suggesting a low 
specificity of the polymerase during transcription. In addition, all gene junction regions were 
cloned into the shuttle vector pMW10 carrying the promoterless lacZ gene to identify 
functional promoter sites. Bidirectional active promoters were found in the strand-switch 
regions. The results of RT-PCR and cDNA blotting indicated that transcriptional linkage 
occurred between different operons, indicating a lack of transcription termination within the 
LOS gene cluster. Moreover, the results of semi-quantitative RT-PCR and real-time RT-PCR 
showed that both DNA strands were transcribed but transcription of the coding strand was at a 
higher rate, and both sense and antisense transcripts of each LOS gene examined were 
responsive to acid stress. The results presented here give a better insight into transcription of 
the LOS synthesis gene cluster of C. jejuni.  
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INTRODUCTION 
The lipooligosaccharide (LOS) of C. jejuni is a major surface molecule consisting of two 
parts: the core oligosaccharide and the lipid A. It is involved in virulence (24) and induction 
of the Guillain-Barré syndrome (GBS), an autoimmune disorder of the peripheral nervous 
system (117). This crucial molecule is partly encoded by the wlaII gene cluster that has been 
shown to exhibit a high degree of variation among strains (32, 80). Previously, Viraj and 
colleagues (74) cloned and sequenced the wlaII-LOS synthesis gene cluster from the C. jejuni 
strain HB 93-13, which was originally isolated from a GBS patient in China (40). It contains 
13 consecutive genes: waaC, htrB, wlaNC, wlaND, cgtA, cgtB, cstII, neuC, neuB, neuA, 
wlaVA, wlaQA, and waaF genes. This gene cluster is classified as a class A LOS gene cluster 
as previously described (32, 80). The waaC gene contributes to the synthesis of both LOS 
inner core and capsule carbohydrate (45). The htrB gene encodes a putative acyltransferase 
involved in lipid A synthesis. The wlaND, cgtA, cgtB, cstII, neuB, neuC, neuA, and waaF 
genes are essential for the formation of human ganglioside-like LOS structures, which can 
induce Guillain-Barré syndrome (35, 37, 62, 63, 76, 117). Mutating the wlaVA gene in a strain 
HB 93-13 did not affect the LOS structure, the LOS sugar composition, and the ganglioside 
mimicry (Viraj N. Perera, unpublished data). The wlaNC and the wlaQA gene are proposed to 
encode for a putative glucosyltransferase and a putative glycosyltransferase, respectively (32, 
81). These studies, relating to the LOS gene cluster of C. jejuni, focussed on functional 
characterisation of the LOS genes, while little information on gene regulation is known. In 
this study the transcription of the LOS synthesis genes was analysed for C. jejuni strain HB 
93-13.  
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MATERIALS AND METHODS 
Bacterial strains and growth conditions 
C. jejuni strains, including HB 93-13 (40), ATCC 43446, OH 4382 (3), NCTC 11168, 81116 
(78), and all Penner serotype (1 to 60) strains and variant strain of Penner serotype 4 
(Biotechnology laboratory, RMIT University, Australia), were grown on Columbia agar plates 
supplemented with 5% (v/v) defibrinated horse blood under microaerobic conditions at 37ºC 
for 16 h unless otherwise stated. Escherichia coli was grown in Luria-Bertani (LB) broth or 
agar at 37ºC for 16 h. Media were supplemented with kanamycin (50 µg/ml) when 
appropriate. 
Primer design and definition 
DNA sequence analysis was performed using Clone manager version 6 (Scientific and 
Educational Software, USA). Primers were designed using the LOS synthesis gene cluster of 
C. jejuni HB 93-13 (accession no. AY297047) unless otherwise indicated. All primers were 
purchased from Sigma Genosys. The primers, which were used to amplify gene-specific 
regions (approximate 500 bp), were named after the gene they were amplifying, such as 
WaaC-F and WaaC-R. The primers, which were used to amplify the gene junction regions 
(300 to 600 bp), were designated as co-primer such as Co-waaC-F and Co-htrB-R. The 
primers, which were used for real-time quantitative RT-PCR (103 to 128 bp), were named as 
q-primer such as q-waaC-F and q-waaC-R. All oligonucleotide primers used in this study are 
listed in Table 3.1.  
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Table 3.1. Oligonucleotide primers used for gene regulation studies 
Name Sequence Name Sequence 
Cj1132c-F 
Cj1132c-R 
WaaC-F  
WaaC-R 
HtrB-F 
HtrB-R 
WlaNC-F 
WlaNC-R 
WlaND-F 
WlaND-R 
CgtA-F 
CgtA-R 
CgtB-F 
CgtB-R 
CstII-F 
CstII-R 
NeuB-F 
NeuB-R 
NeuC-F 
NeuC-R 
NeuA-F 
NeuA-R 
WlaVA-F 
WlaVA-R 
WlaQA-F 
WlaQA-R 
WaaF-F 
WaaF-R 
Co-cj1132c-F 
Co-waaC-R 
Co-waaC-F 
Co-htrB-R 
Co-htrB-F 
Co-wlaNC-R 
Co-wlaNC-F 
Co-wlaND-R 
Co-wlaND-F 
GCTTTATTCCACGCCCGTTA† 
GTGAGAGTGTGCCAGATGTT† 
CCGTGGTTTTGCAATTTATC† 
CCCACATGTATGAGTATGTT† 
AAAGAACGCGATAAATTGTC 
ATAAACAGGGATGATCAAAG  
TGTTTTGCCAAGTAATGCTA 
TTCATCTTCTTGCCAAATGT 
AGATGAACACTCACTCAATA 
CTACACTTAATGCTCGATTT 
TGCTTATTCATCCCTTTTAG  
TATAAGCCACTCATCTTTTG  
TTTAAAACCAACTGCAACTC    
AAGATATGAAGGTGTGAAAG  
ACCAAGCTCATCTAGAAAAT  
TCACTAGAAGGTATGAGTAT  
AACCGCTTAGAAGATATGGG  
TGTGACTTGCTCTTCTTAG  
GCCACGCTATATCAAAACTA  
CCTTGAGCCAACTAAAATTC 
TTGTTGTAAGCAGTGATAGT  
AAATCCTCCAAACAGTCAAT  
TTCTTTTAGCGGATCTTTTC  
TCTTCTAGTAGGTCAAGATA  
GCCATAATTCAAACGCTCAT  
CTTGCGATTTTATCTCAAG  
AAGATGCCCAGTTTATCCTT† 
AAGTTCTTGTTCGGCTTTTC† 
AGGCAAAGGCAAAAACTCAC† 
TTTTAAGGGCAGGGCATAGA† 
AGGAAATGATAGCGGTCCAA 
AAAGCCAGGGCATCTATAAG 
GAGCAAGCCTTATCGCACAA 
CAAGCACTTCATCAGCATCA 
GAACATTTAGAATTTGCACAAAG  
GATAACGCTATCTAAACATTCTC  
TCGGGGAAAACGCTAAGGAA 
Co-cgtA-R 
Co-cgtA-F 
Co-cgtB-R 
Co-cgtB-F 
Co-cstII-R 
Co-cstII-F 
Co-neuB-R 
Co-neuB-F 
Co-neuC-R 
Co-neuC-F 
Co-neuA-R 
Co-neuA-F 
Co-wlaVA-R 
Co-wlaVA-F 
Co-wlaQA-R 
Co-wlaQA-F 
Co-waaF-R 
q-htrB-F 
q-htrB-R 
q-waaC-F 
q-waaC-R 
q-cgtB-F 
q-cgtB-R 
q-cstII-F 
q-cstII-R 
q-wlaQA-F 
q-wlaQA-R 
q-waaF-F 
q-waaF-R 
q-rpoA-F 
q-rpoA-R 
23S rRNA-F 
23S-rRNA-R 
SLIC1 
SLIC2 
Anti-SLIC 
TCCTTTATGCCCCTCCCCTA  
TTGAAAGAACCAGGAGATTG  
ATTGTAGCGTTCTCTATGTG  
TGCTACTTTCACACCTTCAT  
AGTTCGGTCTCATATTCTTG  
CTTCTAGTGAGGCTTATGGA  
GCCTTACTCATCTCATCTTC  
AAAAAGCAGCTAAGCAAGAG  
CTAAAGCCTTATCGGTTGAA  
TTCCATCGCTTAGATTTGAG  
GCACTTTATCGATTGTAGTA  
CGATTTAGCAGGGATTTGTA  
AAACATAGAAACCCCATCAG  
AGGACAAAGAGCTGTAGTTA  
AGAATTATGGCGAAGATGTG  
ACGCTATTTCACAAGCATCA  
GCGTAAAGATAGGGCTTGTT  
TTATGCCTGATTGTATCTTG 
TTGAGTGTATTGAGGAAAAC 
AATTAGCGCCAAAATTCAATC 
TTAAAGCAAAAGCCAAATGTG 
GAATTATTATTAGGCACGTAATG 
GTTAAAATCAATATGGCTGAAG 
CTATATTGCTTATGTCCTAAC 
ACTAGAAGGTATGAGTATATC 
ATCTCTTTAAACGCTATTTCAC 
GAAGAAAATTTAGGCACTTTTG 
TTTATGGCTCTTTGGTTTC 
TTCTTTGCGTAAAGATAGG 
GCTTTAGATGCTTTCTTTAC† 
ATTTGTCCATCAGTTGTTAC† 
TGAGCAAGTTGAAGCTAGTG† 
AATAGAACGCTCTCCTACCA† 
NH2-TCGTTTTTGTCGAGTTTGAG 
AAGGGCAGGGCATAGAGTT 
TTCATAGCGGTCCACCGACA 
AAP 
Linker              
GGCCACGCGTCGACTAGTACGGGIIGGIIGGGIIG (Invitrogen)  
PO4-ACTAGTGTCGGTGGACCGCTATGAATTCCTGTTGTGCCAAGCGATGATAC-NH2 
†, Primers were designed using the genome of C. jejuni NCTC 11168 (accession no. 
AL111168), the other primers were designed using the LOS gene cluster sequence of C. jejuni 
HB 93-13 (accession no. AY297047).  
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Sequencing of the Cj1132c and waaC gene junction region 
Using the genome sequence of C. jejuni NCTC 11168 (81), the primers Cj1132c-F and Co-
htrB-R were designed to amplify a 1,911 bp DNA fragment containing the partial Cj1132c, 
entire waaC, and partial htrB genes. PCR was carried out by using pfu polymerase (Roche). 
The PCR conditions were as follows: 94ºC for 5 min; 35 cycles of 94ºC for 30 s, 55ºC for 1 
min, 72ºC for 4 min; and 72ºC for 7 min. The PCR product was sequenced by using the ABI 
sequencing mix V 3.1 (ABI) according to the manufacturers’ instructions.   
Rapid amplification of cDNA ends (RACE) 
The 5' RACE system version 2.0 (Invitrogen) was used to locate transcriptional start sites and 
promoters according to the manufacturer’s instructions. Reverse transcription was carried out 
by using Omiscript reverse transcriptase (Qiagen) in which 5 µg of total RNA was used as the 
template for cDNA synthesis. All RACE primers used are described in Table 3.2. PCR was 
carried out by using Taq polymerase (ABI) as previously described. The PCR conditions were 
as follows: 95ºC for 6 min; 45 cycles of 95ºC for 30 s, 55ºC for 30 s, 72ºC for 30 s; and 72ºC 
for 7 min. A PCR product was cloned into the pCR2.1 vector using the TA cloning kit 
according to the manufacturer’s instructions (Invitrogen). Plasmid DNA was isolated from 
white colonies using the mini-prep procedure as previously described (6) and digested by 
restriction enzymes to confirm positive clones. The pCR2.1 vector carrying the expected 
insert was purified using the QIAprep spin miniprep kit (Qiagen) and subsequently sequenced 
by using the ABI sequencing mix V 3.1 (ABI) according to the manufacturers’ instructions.   
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Table 3.2. Primers used for mapping transcriptional start sites and promoter regions using 
RACE 
Gene RT and PCR primers† RT and PCR primers§ 
Cj1132c 
waaC 
htrB 
wlaNC 
wlaND 
cgtA 
cgtB 
cstII 
neuB 
neuC 
neuA 
wlaVA 
wlaQA 
waaF 
Not determined 
WaaC-R and AAP/Co-waaC-R 
HtrB-R and AAP/Co-htrB-R 
WlaNC-R and AAP/Co-wlaNC-R 
WlaND-R and AAP/Co-wlaND-R 
CgtA-R and AAP/Co-cgtA-R 
CgtB-R and AAP/Co-cgtB-R 
CstII-R and AAP/Co-cstII-R 
NeuB-R and AAP/Co-neuB-R 
NeuC-R and AAP/Co-neuC-R 
NeuA-R and AAP/Co-neuA-R 
WlaVA-R and AAP/Co-wlaVA-R  
WlaQA-R and AAP/Co-wlaQA-R 
WaaF-R and AAP/Co-waaF-R 
Cj1132c-F and AAP/Co-cj1132c-F 
WaaC-F and AAP/Co-waaC-F 
HtrB-F and AAP/Co-htrB-F 
WlaNC-F and AAP/Co-wlaNC-F 
WlaND-F and AAP/Co-wlaND-F 
CgtA-F and AAP/Co-cgtA-F 
CgtB-F and AAP/Co-cgtB-F 
CstII-F and AAP/Co-cstII-F 
NeuB-F and AAP/Co-neuB-F 
NeuC-F and AAP/Co-neuC-F 
NeuA-F and AAP/Co-neuA-F 
WlaVA-F and AAP/Co-wlaVA-F 
WlaQA-F and AAP/Co-wlaQA-F 
Not determined 
†, RT and PCR primers used for mapping start site of sense transcript of each gene; §, RT and 
PCR primers used for mapping start site of antisense transcript of each gene.  
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Single-stranded ligation of complementary ends (SLIC) 
The SLIC procedure used in this study was modified from a previous study (20). The first 
strand cDNA synthesis was carried out using the Omiscript reverse transcriptase (Qiagen), 3 
µg of total RNA was used as the template. The primer SLIC1, which is located 535 bp 
downstream of the waaC start codon and contains the amine C3 group at its 5' end, was used 
as the anti-sense primer for cDNA synthesis. Primers and unincorporated dNTPs were 
removed from the reverse transcription product using the Geneclean kit according to the 
manufacturer’s instructions. The 10 × ligation buffer was prepared as follows: 500 mM of 
Tris-HCL (pH 8.0), 100 mM of MgCL2, 100 µg/ml of BSA, 10 mM of ATP, and 10 mM of 
hexamine cobalt chloride. This buffer was sterilized by filtration through a 0.22 µm 
membrane, and stored at -20ºC. The 3' end cDNA was ligated with the oligonucleotide linker 
that contains the phosphate group (PO4) at the 5' end and the amine C3 group (NH2) at the 3' 
end. The ligation reaction was prepared in a total volume of 10 µl containing 1 × ligation 
buffer, 100 ng of linker, 24% (v/v) of PEG 6000, 1 µl of purified cDNA, and 20 U of T4 RNA 
ligase (New England BioLabs). The reaction mixture was incubated at 22ºC for 48 h. The 
ligation product was purified using the Geneclean kit as previously described. The purified 
ligation product was used as the template for the nested PCR using primers Anti-SLIC and 
SLIC2. The anti-sense primer Anti-SLIC is complementary to the oligonucleotide linker. The 
sense primer SLIC2 is identical to the 5' cDNA end and is located 175 bp downstream of the 
waaC start codon. PCR was carried out using Taq polymerase (ABI). The PCR conditions 
were as follows: 94ºC for 5 min; 45 cycles of 94ºC for 30 s, 60ºC for 1 min, 72ºC for 1 min; 
and 72ºC for 7 min. The PCR product was cloned into the pCR2-1 vector and sequenced as 
previously described in the RACE method. All SLIC primers and linkers designed in this 
study are shown in Table 1. 
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Introducing putative promoters into a reporter gene plasmid in C. jejuni 
Each gene junction region between the Cj1132c gene and the waaF gene was amplified from 
isolated genomic DNA of C. jejuni strain HB 93-13 using Taq polymerase (ABI). All co-
primers used are listed in Table 3.3. PCR products were cloned into the PCR2.1 vector using 
the TOPO TA cloning kit (Invitrogen). Digestion of isolated plasmids with appropriate 
restriction enzymes was performed to confirm positive clones and determine the insert 
orientation. PCR2.1 carrying each gene junction region was digested with BamHI/XbaI, 
ligated into BamHI/XbaI-digested pMW10 carrying the promoterless lacZ gene (115), and 
introduced into chemically competent E. coli strain S17.1 by heat shock (91). The pMW10 
carrying each gene junction region was confirmed by restriction mapping. 
Various C. jejuni strains were tested for their ability to take up and host the pMW10 plasmid 
from E. coli. These bacterial strains included HB 93-13 (GBS), ATCC 43446, OH 4382 
(GBS), NCTC 11168, NCTC 81116, variant strain of Penner serotype 4, and all Penner 
serotype (1 to 60) strains. Recombinant pMW10 plasmids were isolated from E. coli and 
introduced into various C. jejuni strains using electro-transformation (108) and/or natural 
transformation. For natural transformation, at least 10 µg of plasmid was mixed with 300 µl of 
C. jejuni cells suspended in Mueller-Hinton broth and the mixture was transferred onto 
Mueller-Hinton agar plates and incubated at 37˚C under microaerobic conditions overnight. 
After incubation, bacterial cells were harvested in Mueller-Hinton broth and grown on 
Columbia agar plates supplemented with 5% (v/v) defibrinated horse blood and kanamycin 
under microaerobic conditions at 42ºC for 48 h. The C. jejuni transformants carrying 
recombinant plasmids were confirmed by restriction mapping.  
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Table 3.3. Primers used for co-transcriptional analysis of LOS genes 
Gene junction region RT primers† RT primers‡ PCR primers 
Cj1132c/waaC 
waaC/htrB 
htrB/wlaNC 
wlaNC/wlaND 
wlaND/cgtA 
cgtA/cgtB 
cgtB/cstII 
cstII/neuB 
neuB/neuC 
neuC/neuA 
neuA/wlaVA 
wlaVA/wlaQA 
wlaQA/waaF 
WaaC-R 
HtrB-R 
WlaNC-R 
WlaND-R 
CgtA-R 
CgtB-R 
CstII-R 
NeuB-R 
NeuC-R 
NeuA-R 
WlaVA-R 
WlaQA-R 
WaaF-R 
Cj1132c-F  
WaaC-F  
HtrB-F  
WlaNC-F  
WlaND-F  
CgtA-F  
CgtB-F  
CstII-F  
NeuB-F  
NeuC-F  
NeuA-F  
WlaVA-F  
WlaQA-F 
Co-cj1132c-F/Co-waaC-R 
Co-waaC-F/Co-htrB-R 
Co-htrB-F/Co-wlaNC-R 
Co-wlaNC-F/Co-wlaND-R 
Co-wlaND-F/Co-cgtA-R 
Co-cgtA-F/Co-cgtB-R 
Co-cgtB-F/Co-cstII-R 
Co-cstII-F/Co-neuB-R 
Co-neuB-F/Co-neuC-R 
Co-neuC-F/Co-neuA-R 
Co-neuA-F/Co-wlaVA-R 
Co-wlaVA-F/Co-wlaQA-R 
Co-wlaQA-F/Co-waaF-R 
†, Primers used for cDNA synthesis from sense transcript containing each gene junction 
region; ‡, primers used for cDNA synthesis from antisense transcript containing each gene 
junction region. 
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To screen for the promoter-positive C. jejuni transformants, C. jejuni strains carrying a 
constructed reporter plasmid were grown at 42ºC under microaerobic conditions for 16 h. The 
gene junction region showing an active promoter in C. jejuni was demonstrated by testing the 
β-galactosidase activity. One full loop of bacterial cells was added to an Eppendorf tube 
containing 250 µl of 0.1% (w/v) X-Gal in PBS and incubated at 37ºC for at least 4 h. Active 
promoters gave the growth media a blue colour.  
Assay of promoter activity 
The C. jejuni strains showing functional promoters in the inserted gene junction regions were 
grown as previously mentioned. The bacterial cells were washed once with 1 ml of cold PBS 
without magnesium and calcium at 3,300 × g for 5 min. The pellet was resuspended in 500 µl 
of cold PBS, and cell density was determined by measuring the OD600. After centrifugation as 
above, the pellet was suspended in 500 µl of lysis buffer [0.1M Tris-HCL (pH 7.8), 0.5% 
(v/v) Triton X-100] and incubated at 37˚C for 20 min. Cell debris was removed by 
centrifuging at 16,000 × g  at 4ºC for 10 min, and the supernatant (cell lysate) was used for 
testing β-galactosidase activity, which was measured by conversion of p-nitrophenol-β-D-
galactopyranoside (PNPG) as previously described (91, 115). The β-galactosidase assay was 
carried out in duplicate.  
Northern blot analysis  
DNA probes were prepared. Chromosomal DNA was isolated from C. jejuni HB 93-13 using 
the cetytrimethylammonium procedure (6), and 100 ng of DNA was used as the PCR 
template. PCR was carried out by using pfu polymerase (Roche) to amplify the gene junction 
regions using co-primers (Table 3.3). The PCR conditions were as follows: 94ºC for 5 min; 35 
cycles of 94ºC for 30 s, 60ºC for 1 min, 72ºC for 1 min; and 72ºC for 7 min. The PCR 
products were gel-purified using the QIAquick gel extraction kit (Qiagen), and a 500 ng 
purified PCR product was labelled with digoxigenin-11-dUTP using the DIG labelling kit 
(Roche) according to the manufacturer’s instructions.  
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Northern blot analysis was performed as described in the DIG system user’s guide book 
(Roche) unless otherwise stated. Both total RNA and mRNA-rich samples were separated on 
a 1.5% (v/v) formaldehyde gel as described in the RNeasy handbook (Qiagen) and 
subsequently blotted onto a Hybond N membrane (Amersham) by upward capillary transfer in 
20 × SSC buffer as previously described (91). The RNA fragments were fixed to the 
membrane by UV-crosslinking for 5 min. Pre-hybridisation buffer was prepared as follows: 
7% (w/v) SDS, 50% (v/v) formamide, 5 × SSC, 0.1% (w/v) N-lauroyl sarcosine, 50 mM 
sodium dihydrogen orthophosphate monohydrate (pH 7.0), 2% (v/v) blocking reagent, and 
yeast tRNA (100 µg/ml). The mRNA-DNA hybridization was performed at 50ºC overnight. 
Detection was performed using the alkaline phosphatase-conjugated anti-DIG antibody and 
the NBT/BCIP substrate. The RNA ladder (0.5-9 kb, Ambion) was used as the standard 
marker. The 23S rRNA gene was used as the positive control. 
RT-PCR 
RNA isolation was performed using RNAzolB (Tel-Test), and the combination of TURBO 
DNase treatment (Ambion) and extraction with acid phenol (125:24:1, pH 4.5, Ambion) was 
used to remove contaminating DNA from the RNA sample according to the manufacturers’ 
instructions. Reverse transcription was carried out by using Omiscript reverse transcriptase 
(Qiagen). All primers used for RT-PCR are described in Tables 3.3 and 3.4. One microgram 
of the purified total RNA sample was used as the template for cDNA synthesis. RNase-free 
water was substituted for reverse transcriptase for the negative control. Genomic DNA of C. 
jejuni HB 93-13 was used instead of RNA for the positive control. After cDNA synthesis, 10 
µl of RNase A solution (20 µg/ml) was added to the samples and they were incubated at 37°C 
for 20 min. After the RNase treatment, two types of PCR were performed. The first one, a 
conventional PCR, was carried out in a GeneAmp PCR system 2400 (Perkin Elmer) using 
Taq polymerase (ABI) and/or pfu polymerase (Roche) according to the manufacturers’ 
instructions. The PCR conditions were programmed on the GeneAmp 2400 (Perkin Elmer) as  
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Table 3.4. Gene-specific primers used for transcriptional analysis of individual genes 
Genes RT primers† RT primers‡ PCR primers 
Cj1132c 
waaC 
htrB 
wlaNC 
wlaND 
cgtA 
cgtB 
cstII 
neuB 
neuC 
neuA 
wlaVA 
wlaQA 
waaF 
23S rRNA 
Cj1132c-R 
WaaC-R 
HtrB-R 
WlaNC-R 
WlaND-R 
CgtA-R 
CgtB-R 
CstII-R 
NeuB-R 
NeuC-R 
NeuA-R 
WlaVA-R 
WlaQA-R 
WaaF-R 
Not determined 
Cj1132c-F  
WaaC-F  
HtrB-F  
WlaNC-F  
WlaND-F  
CgtA-F  
CgtB-F  
CstII-F  
NeuB-F  
NeuC-F  
NeuA-F  
WlaVA-F  
WlaQA-F  
WaaF-F  
Not determined 
Cj1132c-F/Cj1132c-R 
WaaC-F/WaaC-R 
HtrB-F/HtrB-R 
WlaNC-F/WlaNC-R 
WlaND-F/WlaND-R 
CgtA-F/CgtA-R 
CgtB-F/CgtB-R 
CstII-F/CstII-R 
NeuB-F/NeuB-R 
NeuC-F/NeuC-R 
NeuA-F/NeuA-R 
WlaVA-F/WlaVA-R 
WlaQA-F/WlaQA-R 
WaaF-F/WaaF-R 
23S-rRNA-F/23S-rRNA-R 
†, Primers used for cDNA synthesis from sense transcript of each gene; ‡, primers used for 
cDNA synthesis from antisense transcript of each gene. 
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follows: 94°C for 3 min; 35-40 cycles of 94°C for 30 s, 58-60°C for 1 min, 72°C for 1 min; 
and 72°C for 7 min. The second type, a semi-quantitative PCR, was performed as previously 
described, except that the PCR conditions were as follows: 94°C for 3 min; 25-35 cycles of 
94°C for 30 s, 45°C for 1 min, 72°C for 1 min; and 72°C for 7 min.  
Southern blot analysis  
Southern blot analysis was performed as described in the DIG system user’s guide book 
(Roche) unless otherwise stated. Briefly, RT-PCR products were separated on a 2.5 % (w/v) 
agarose gel and blotted onto a Hybond N membrane (Amersham) by upward capillary transfer 
in 20 × SSC buffer overnight as previously described (91). The cDNA fragments were fixed 
to the wet membrane by UV-crosslink for 5 minutes. Pre-hybridization buffer was prepared as 
follows: 5 × SSC, 0.1% (w/v) N-lauroyl sarcosine, 0.02% (w/v) SDS, and 1% (v/v) blocking 
reagent. DNA probes were those described in northern blot analysis. The cDNA-DNA 
hybridisation was performed at 68°C overnight. Detection of hybridisation was performed as 
described for northern blot analysis. 
Treatment of C. jejuni with acid stress and RNA preparation 
C. jejuni HB 93-13 was grown in 30 ml of brucella broth with gentle shaking under 
microaerobic conditions at 37ºC for 19 h, and 100 µl of bacterial culture was aliquoted into 2 
bottles of brucella broth (30 ml) and incubated for another 19 h. After incubation, 1 ml of 
brucella broth, which had been supplemented with concentrated HCl and pre-warmed at 37ºC, 
was added to the first culture bottle to obtain a final pH of 5.5 (acid stress). A pH of 5.5 was 
selected as acid stress since C. jejuni showed normal growth in brucella broth at pH 6.0, 
inhibited growth at pH 5.5, and no growth at pH 5.0. The second culture bottle, which had 
been added with 1 ml of pre-warmed brucella broth, was used as the calibrator (normal gene 
expression level). The incubation was performed at 37ºC with gentle shaking under 
microaerobic conditions. Culture samples were collected after incubation for 15 min and 
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transferred directly into a 1/10 volume of cold 10 × stop solution [5% (v/v) phenol in 100% 
ethanol] to halt transcription and RNA degradation. RNA samples were isolated using the 
RNAgents total RNA isolation system (Promega), and DNA decontamination was performed 
using the TURBO DNA-free Kit (Ambion).  
Quantitative real-time RT-PCR  
Both forward and reverse primers were separately used for reverse transcription. Primers q-
htrB-R, q-waaC-R, q-cgtB-R, q-cstII-R, q-wlaQA-R, q-waaF-R, or q-rpoA-R were used for 
reverse transcription for quantification of forward transcripts of the htrB, waaC, cgtB, cstII, 
wlaQA, waaF, or rpoA genes, respectively. Primers q-htrB-F, q-waaC-F, q-cgtB-F, q-cstII-F, 
q-wlaQA-F, q-waaF-F, or q-rpoA-F were used for reverse transcription for quantification of 
reverse transcripts of the htrB, waaC, cgtB, cstII, wlaQA, waaF, or rpoA genes, respectively.  
The cDNA synthesis was performed using the SuperScript II reverse transcriptase 
(Invitrogen). One microgram of RNA, 50 ng of q-primer either sense primer or anti-sense 
primer, and 1 µl of dNTP mix (10 mM each) in a total volume of 12 µl was heated at 65°C for 
5 min and immediately chilled on ice for at least 5 min. For each gene, dilution series of 
newly synthesized cDNA was performed and included in quantitative PCR to examine the 
efficiency of PCR. The master mix was prepared in a total volume of 7 µl, which consisted of 
4 µl of 5 × first-strand buffer, 2 µl of 0.1 M DTT, and 1 µl of RNase-free water. The master 
mix was distributed into the reaction tube containing the mixture of heated RNA, primer, and 
dNTP. The tube was gently mixed and incubated at 42°C for 2 min followed by addition of 1 
µl of revere transcriptase (200 u/µl). Reverse transcriptase was substituted by RNase-free 
water for the negative control. The reaction mixture was gently mixed, incubated at 42°C for 
50 min, and heated at 70°C for 15 min. After cDNA synthesis, 10 µl of RNase A solution (20 
µg/ml) was added and the samples were incubated at 37°C for 20 min and followed by 
addition of 220 µl of water.  
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Quantitative PCR was performed on the MyiQ (Bio-Rad) using iQ SYBR Green Supermix 
(Bio-Rad) according to the manufacturer’s instructions. The PCR reaction was performed in a 
total volume of 20 µl consisting of 10 µl of iQ SYBR Green Supermix and 10 µl of master 
mix, which consisted of 1 µl of forward primer (50 ng/µl), 1 µl of reverse primer (50 ng/µl), 3 
µl of diluted cDNA solution, and 5 µl of water. Primers q-htrB-F/q-htrB-R, q-waaC-F/q-
waaC-R, q-cgtB-F/q-cgtB-R, q-cstII-F/q-cstII-R, q-wlaQA-F/q-wlaQA-R, q-waaF-F/q-waaF-
R, or q-rpoA-F/q-rpoA-R were used for amplifying the cDNA-specific fragments for the htrB, 
waaC, cgtB, cstII, wlaQA, waaF, or rpoA gene, respectively. Each PCR was performed in 
duplicate. The samples that showed a difference in cycle threshold (CT > 1) were repeated. 
PCR conditions were as follows: cycle 1 (1 ×): 95°C for 5 min; cycle 2 (40 ×): 95°C for 30 s, 
60°C for 30 s, 72°C for 30 s; cycle 3 (100 ×): 95°C for 10 s (decrease setpoint temperature 
after cycle 2 by 0.5ºC, and enable melt curve data collection and analysis). Each specific 
amplicon was verified both by the presence of a single melting temperature peak and by the 
presence of a single band of expected size on a 3% agarose gel after electrophoresis. Cycle 
threshold values were determined by the MyiQ software (Bio-Rad). The relative changes (X-
fold) in gene transcription between the induced and calibrator samples were calculated using 
the 2
-∆∆CT
 method as described by Livak and Schmittgen (64). Two internal control genes 
(rpoA and htrB) were included. The rpoA gene, which encodes the alpha subunit of RNA 
polymerase, was used as internal negative control as its expression was found to be constant 
under different environmental conditions (59, 97). The htrB gene, which encodes a putative 
acyltransferase involved in lipid A synthesis, was used as the internal positive control as its 
expression was highly up regulated under acid stress (Chapter IV). Relative expression values 
of -2 < X > 2 were considered to be significantly down or up regulated.  
 
 
 
 74
RESULTS  
Identification of transcriptional start sites and promoter regions 
To locate the start site and promoter region upstream of the waaC start codon on the upper 
DNA strand, 5' RACE was performed. The antisense primer WaaC-R, which is located 553 
bp downstream of the waaC start codon, was used for cDNA synthesis. The homopolymeric 
dCTP tract was tailed to the 3' cDNA end by the terminal deoxynucleotidyl transferase 
enzyme. Nested PCR with primers AAP and Co-waaC-R was performed to amplify the 
dCTP-tailed cDNA. After amplification, the amplicon was cloned into the PCR2.1 vector and 
subsequently sequenced. For identification of transcriptional start sites and promoters for 
other LOS genes on both upper and bottom DNA strands, the same RACE principle was 
applied (Table 2). Sequence analysis of several cDNA clones identified multiple 5' termini for 
both the bottom and the top strands. Multiple start sites were observed for the genes waaC [26 
bp upstream of the start codon at nucleotide A (-26, A), (-12, A), 37 bp downstream of the 
start codon at nucleotide A (+37, A), (+58, T), (+96, T)], cgtB [(-22, A), (+36, C), (+48, T)], 
cstII [(-27, A), (-17, C), (+19, G), (+110, A)], and wlaVA [(+74, C), (+96, A), (+111, A), 
(+199, T)]. One start site was observed for the genes Cj1132c (-25, C), cgtA (-23, A), neuB 
(+114, T), wlaQA (-27, T), and waaF (-31, A). Although multiple start sites were identified, 
even for a single gene, recognizable promoter regions were only located upstream of the most 
upstream initiation sites for the Cj1132c, waaC, cgtA, cgtB, cstII, wlaQA, and waaF genes 
(Table 3.5, also see Fig. 3.1A).  
To confirm the start sites, which were previously inferred by the RACE method, SLIC was 
performed. A previous study showed that S1 nuclease protection, primer extension, and SLIC 
all identified multiple potential start sites of the human β1 subunit gene. However among 
these positions, the major transcriptional start site that was inferred from SLIC corresponded 
to the most upstream site (90). In this study, the start site upstream of the waaC start codon 
was selected to be confirmed. Multiple cDNA clones were observed, which indicated multiple  
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Table 3. 5. Promoter regions, initiation sites, ribosomal binding sites (RBS), and start codons 
(SC) in the LOS gene cluster of C. jejuni HB 93-13 
Gene                            Promoter region +1 Gap RBS Gap SC 
waaC tttgccatttttaacctttttttaaataatttcgctaaaatcatagc a 16 aggct 4 atg 
cgtA taataaaaatataaaaaattaattaatttttaggtataatcactat a 5 aggag 12 atg 
cstII ttattataatttaattataacataaaatctattttgataaaatcgtt a 14 tggaa 7 atg 
waaF gatagaaagttgtggcatatttttcctaaattttgttaaaataat a 21 aggaa 4 atg 
Cj1132c
*
 ctattttcattaaaagcctaatattttaaaatttttgctatgattttagc g 15 aggtt 4 atg 
cgtB
*
 aagatttatttttaacgattttatcaaaatagattttatgttataattaaat t 11 aggaa 5 atg 
wlaQA
*
 aggtgtataaaaattttcataaatttcctaaactttgatagaattgttttt a 17 aggaa 5 atg 
*
, Inverted and complementary strands shown; underlined letters indicate the putative -10 
region; a bold letter (left) is the nucleotide at the -35 position; a bold letter (right) is the 
nucleotide at the -10 position; +1, is the most upstream transcriptional start site. 
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Figure 3.1. wlaII-LOS synthesis gene cluster of C. jejuni HB 93-13 (A; accession no. 
AY297047) and location of primers (B). For A, open arrows indicate predicted transcription 
direction for each gene; elbow arrows with numbers indicate transcriptional start sites and 
their transcription directions. B, example of primer distribution along the waaC and htrB 
genes. Elbow arrows indicate primers used in this area. 
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start sites. In this experiment, only the clones carrying the largest cDNA fragments were 
sequenced as these most likely indicated the most upstream initiation site. The results showed 
that the most upstream start site was located at nucleotide A, 26 bp upstream of the waaC start 
codon (-26, A). This position is identical to the transcriptional start site upstream of the waaC 
start codon that was previously identified by the RACE method.  
Functional characterisation of promoter regions 
Individual gene junction regions were amplified from genomic DNA of C. jejuni HB 93-13 
and then ligated into the pMW10 plasmid carrying the promoterless lacZ gene (115). The 
ligation product was initially introduced into various C. jejuni strains (see method). 
Transformation was performed using natural transformation and electro-transformation. 
Several attempts were made without success. Therefore an alternative approach was taken in 
which we cloned each gene junction region into the pMW10 plasmid and introduced the 
resulting constructs into E. coli. Following verification of the correct constructs they were 
purified from E. coli and introduced into various C. jejuni strains, again using both natural 
transformation and electro-transformation. However, again none of the C. jejuni strain tested 
was found to be able to host the pMW10 plasmid. Possibly, C. jejuni and E. coli harbour 
different restriction modification systems, which creates a barrier for interstrain plasmid 
transfer (2). Additional C. jejuni strains, all Penner serotype (1 to 60) strains, were tested for 
their ability to take up and host the recombinant pMW10 plasmids from E. coli using natural 
transformation. Only C. jejuni Penner serotype 59 could be transformed with the recombinant 
pMW10 plasmids. Therefore, this strain was used as the recipient for interstrain plasmid 
transfer. The β-galactosidase activity assay showed that the Cj1132c/waaC, cgtB/cstII, and 
wlaQA/waaF gene junction regions possessed functional promoters. Among these, the 
wlaQA/waaF region showed the strongest promoter strength (Table 3.6, 13.12A). This is 
consistent with our previous results that identified functional promoters located in the same 
regions where the transcriptional start sites and the potential promoters were inferred using 
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Table 3.6. β-Galactosidase activity of the C. jejuni transformants 
Transfo
-rmant  
Junction region 
cloned in pMW10 
Location
*
 Direction Colony color Miller 
unit 
1.2D 
2.3H 
2.4A 
3.1B 
4.1A 
5.1W 
6.1A 
6.4H 
7.1A 
8.1A 
9.1D 
9.2A 
10.1B 
10.13A 
11.1A 
12.1C 
12.2A 
13.1A 
13.12A 
14 
Cj1132c/waaC 
waaC/htrB 
waaC/htrB 
htrB/wlaNC 
wlaNC/wlaND 
wlaND/cgtA 
cgtA/cgtB 
cgtA/cgtB 
cgtB/cstII 
cstII/neuB 
neuB/neuC 
neuB/neuC 
neuC/neuA 
neuC/neuA 
neuA/wlaVA 
wlaVA/wlaQA 
wlaVA/wlaQA 
wlaQA/waaF 
wlaQA/waaF 
pMW10 without 
insert 
126450-126859† 
142-700 
142-700 
1009-1526 
2321-2876 
3691-4255 
4733-5223 
4733-5223 
5732-6268 
6799-7126 
7756-8204 
7756-8204 
8757-9377 
8757-9377 
9528-10052 
10277-10846 
10277-10846 
11072-11646 
11072-11646 
1-10266‡ 
S 
S 
O 
O 
O 
O 
O 
S 
S 
O 
O 
S 
O 
S 
O 
O 
S 
O 
S 
- 
Dark blue 
White 
White 
White 
White 
White 
White 
White 
Dark blue 
White 
White 
White 
White 
White 
White 
White 
White 
Light blue 
Dark blue 
White 
320 
1 
1 
2 
2 
5 
3 
4 
419 
3 
1 
1 
2 
4 
3 
5 
4 
41 
570 
5 
*
 , Location in the LOS gene cluster of C. jejuni HB 93-13 (accession no. AY297047); †, 
DNA sequence for the Cj1132c/waaC region was taken from the genome of C. jejuni NCTC 
11186 (accession no. AL111168) and is identical to that of C. jejuni HB 93-13 (data not 
shown); ‡, entire nucleotide sequence of pMW10 (accession no. AJ001494); S, indicates the 
same orientation of the insert and the lacZ gene; O, indicates the opposite orientation of the 
insert relative to the lacZ gene.  
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RACE and/or SLIC methods. Plasmids showing no activity were sequenced to verify that no 
mutations were introduced during PCR and cloning. Plasmid sequence analysis showed that 
no mutations were present in the promoter-negative regions. Furthermore, the sizes of the 
inserts that were cloned into the pMW10 (Table 3.6) were large enough for the promoter 
activity assay to be successfully performed as previously shown (115). Therefore, it is likely 
that the other LOS gene junction regions, except Cj1132c/waaC, cgtB/cstII, and wlaQA/waaF, 
did not possess a functional promoter. The above conclusions were made assuming that the C. 
jejuni Penner serotype 59 and C. jejuni strain HB 93-13 polymerases recognise the same 
promoter region.  
Transcriptional analysis of LOS genes 
To estimate the transcript sizes, Northern blot analysis was performed. No hybridisation was 
observed for the tested LOS genes, while the positive control, the 23S rRNA gene, did show 
hybridisation (result not shown). Several attempts were made without success. The lack of 
success was probably due to low amounts of LOS mRNA and/or rapid degradation of the 
LOS mRNA. Therefore, an alternative method for transcription analysis, RT-PCR, was used. 
To determine co-transcription of the LOS genes nested RT-PCR was performed. As expected, 
no PCR product was observed for the negative controls without reverse transcriptase, 
confirming the lack of artifacts and DNA contamination in the RNA samples. For the forward 
direction the results showed that cDNA fragments containing the gene junction regions of 
waaC/htrB, htrB/wlaNC, wlaNC/wlaND, wlaND/cgtA, cgtA/cgtB, cgtB/cstII, cstII/neuB, 
neuB/neuC, neuC/neuA, neuA/wlaVA, wlaVA/wlaQA, and wlaQA/waaF were present (Fig. 
3.2A). As expected, the cDNA fragment containing the Cj1132c/waaC gene junction region 
was not detected. This result indicated that the LOS genes (waaF to waaC) were co-
transcribed in the forward direction. For the reverse direction the cDNA fragments containing 
the gene junction regions of waaF/wlaQA, wlaQA/wlaVA, wlaVA/neuA, neuA/neuC, 
neuC/neuB, neuB/cstII, cstII/cgtB, cgtB/cgtA, cgtA/wlaND, wlaND/wlaNC, wlaNC/htrB, 
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htrB/waaC, and waaC/Cj1132c were detected (Fig. 3.2B and 3.2C). This result indicated that 
the LOS gene cluster (waaF to waaC) and its adjacent Cj1132c gene were co-transcribed in 
the reverse direction.  
To determine transcription of individual LOS genes, RT-PCR was performed. The results 
showed that the Cj1132c gene was transcribed in the reverse direction only as previously 
predicted (Fig. 3.1A). The other genes, including waaC, htrB, wlaNC, wlaND, cgtA, cgtB, 
cstII, neuB, neuA, wlaVA, wlaQA, and waaF, were transcribed in both forward and reverse 
directions since both sense and antisense transcripts for each gene were detected. Since the 
sizes of the RT-PCR products for sense and antisense transcripts for each gene were 
approximately 500 bp (see primer design), only the forward transcripts are shown (Fig. 3.2D).  
To verify the sense and antisense transcripts indicated by RT-PCR, Southern blot analysis was 
performed. All RT-PCR products obtained from co-transcriptional analysis of LOS genes in 
the reverse direction were selected for confirmation. DNA probes containing the gene 
junction regions were used for hybridisation. The results showed specific hybridisation 
between DNA probes and RT-PCR products, confirming the lack of non-specific RT-PCR 
products (Fig. 3.2E).  
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Figure 3.2. Transcriptional analysis of LOS genes. Arrows indicate 500 bp position. A, co-
transcriptional analysis of genes in the forward direction by nested RT-PCR; a to m, 
transcripts containing gene junction regions of Cj1132c/waaC, waaC/htrB, htrB/wlaNC, 
wlaNC/wlaND, wlaND/cgtA, cgtA/cgtB, cgtB/cstII, cstII/neuB, neuB/neuC, neuC/neuA, 
neuA/wlaVA, wlaVA/wlaQA, and wlaQA/waaF, respectively. B, co-transcriptional analysis of 
genes in the reverse direction by nested RT-PCR; a to m, transcripts containing the same gene 
junction regions as described in A. C, representative negative controls without reverse 
transcriptase (-) for A and B. D, transcriptional analysis of individual genes in the forward 
direction by RT-PCR; 1 to 14, transcripts of the Cj1132c, waaC, htrB, wlaNC, wlaND, cgtA, 
cgtB, cstII, neuB, neuC, neuA, wlaVA, wlaQA, and waaF genes, respectively; minus (-) after 
each number indicates negative control for each gene. E, verification of RT-PCR products 
obtained from B (a to m) by Southern blot analysis.   
 
 
 
a  b   c  d  e   f   g  h    j   i  k  m  l     a   b   c   d   e  f   g   h   i   j    k   l   m    -     - 
1    -     2   -     3   -     4     -   5  -    6   -   7    -  8    -  9   -  10  -  11 -   12  -  13  -  14  - 
a     b    c   d    e    f    g    h    i    j    k    l    m 
A                                                               B                              C
D
E
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Quantification of both sense and antisense transcripts of each LOS gene 
To quantify the amount of both sense and antisense transcripts of each LOS gene, the 
combination of semi-quantitative RT-PCR and quantitative real-time RT-PCR was used. For 
semi-quantitative RT-PCR, all LOS genes were included. For quantitative real-time RT-PCR, 
the waaC, cgtB, cstII, wlaQA, and waaF genes were selected. This selection was based on the 
previous results that these genes possessed the functional promoters upstream of their start 
codons. Before the quantitative data were accepted, three criteria were required. Firstly, no 
PCR product should be detected from the negative control without reverse transcriptase, 
confirming the lack of DNA contamination in the RNA sample. Secondly, the PCR efficiency 
for each gene should be at least 80%. This ensured that low amounts of PCR product were 
due to low expression levels of the genes of interest and not due to low PCR efficiency. 
Thirdly, only one peak for each gene analyzed should be observed in the melting curve, 
confirming the lack of non-specific PCR product. The results showed that the major 
transcripts of the waaC, htrB, wlaNC, wlaND, cgtA, cstII, neuB, neuA, wlaVA, and waaF 
genes were found in the forward direction as more PCR product was obtained for their sense 
transcripts than for their antisense transcripts while the major transcripts of the Cj1132c, cgtB, 
and wlaQA genes were found in the reverse direction (Fig. 3.3 and Table 3.7). Similarly, the 
major transcription directions for all of these genes were consistent with those that were 
previously predicted (Fig. 3.1A). These results indicated that transcription of the non-coding 
DNA strand was at a lower rate. Possibly transcription on this strand was not near a specific 
start site resulting in less mRNA, which has also been described for genes in Leishmania 
major Friedlin (68). To date, bidirectional transcript has not been described for 
Campylobacter genes. A possible reason for this may be that most researchers only use anti-
sense primers for cDNA synthesis or they include both sense and anti-sense primers in the 
same reverse transcription reaction, which would not show transcription of a single gene in 
both directions.  
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Figure 3.3. Semi-quantitative RT-PCR. Arrows indicate 500 bp position; (+) is positive 
control; (-) is negative control; (R) is antisense transcript; and (F) is sense transcript. 
 
 
 
 
 
 
 
 
 
 
Cj1132c              waaC                htrB                wlaNC                wlaND
cgtA                    cgtB                  cstII                  neuB                 neuC 
neuA               wlaVA            wlaQA             waaF 
 +     -   R    F    +     -    R    F     +    -    R     F    +     -     R    F    +     -    R     F 
 +     -     R    F    +     -    R    F   +    -      R    F     +     -    R    F    +     -     R    F 
 +     -   R    F    +    -   R    F   +    -    R    F    +    -    R    
F 
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Table 3.7. Expression of LOS genes under acid stress 
Mean of CT value Transcript¹ 
 Normal Acid 
∆CTC ∆CTS ∆∆CT = 
∆CTC–∆CTS 
X-fold
4
 (2 
–∆∆CT
) 
rpoA-F² 
rpoA-R³ 
htrB-F† 
waaC-F 
waaC-R 
cgtB-F 
cgtB-R 
cstII-F 
cstII-R 
wlaQA-F 
wlaQA-R 
waaF-F 
waaF-R 
24.24 
31.70 
26.06 
26.05 
32.90 
26.50 
21.83 
22.44 
27.27 
29.77 
23.81 
22.43 
25.02 
24.00 
31.52 
20.34 
29.36 
40 
40 
27.07 
29.71 
40 
33.76 
26.71 
25.72 
30.29 
- 
- 
–1.82‡ 
–1.81 
–1.2 
–2.26 
9.87 
1.8 
4.43 
–5.53 
7.89 
1.81 
6.68 
- 
- 
3.66§ 
–5.36 
–8.48 
–16.00 
4.45 
–5.71 
–8.48 
–9.76 
4.81 
–1.72 
1.23 
- 
- 
–5.48 
3.55 
7.28 
13.74 
5.42 
7.51 
12.91 
4.23 
3.08 
3.53 
5.45 
- 
- 
32 
–12 
–128 
–8192 
–32 
–128 
–8192 
–16 
–8 
–12 
–32 
1
, Transcript of genes (for example, rpoA-F and rpoA-R indicate sense and antisense 
transcript of the rpoA gene); 
2
, internal negative control for sense transcript; 
3
, internal 
negative control for antisense transcript; †, internal positive control (only sense transcript was 
determined); CT, indicates cycle threshold value; underlined value indicates an estimated 
value since no product was observed under 40 PCR cycles; ‡, indicates the ∆CTC value of the 
calibrator calculated by subtracting the CT value of the rpoA-F under normal conditions from 
the CT value of the htrB-F under the same conditions (24.24–26.06 = –1.82); §, indicates the 
∆CTS value of the induced sample calculated by subtracting the CT value of the rpoA-F under 
acid stress from the CT value of the htrB-F under the same stress (24.00–20.34 = 3.66); 
4
, X > 
2, gene expression is up-regulated; X < –2, gene expression is down-regulated.  
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The role of both sense and antisense transcripts of each LOS gene in responsiveness of 
C. jejuni to acid stress 
Prior to starting the gene expression study under acid stress, it was found that C. jejuni HB 
93-13 showed inhibited growth in brucella broth at pH 5.5 and no growth at pH 5.0. In 
contrast, other enteric pathogens like Salmonella typhimurium were still able to grow in 
medium at pH 3.0. To survive and cause disease, these bacteria must resist the acidity in the 
host’s stomach. However, this seems most challenging for a fragile bacterium like C. jejuni. 
Therefore, the ability of C. jejuni to resist harsh environments in the human gastrointestinal 
tract is essential for survival, intestinal colonisation, and disease development.  
Generally, bidirectional transcription is a very inefficient way to control the gene expression 
and a waste of resources for the cell as a large portion of each transcript would be unsuitable 
for translation. To examine physiological significance of bidirectional transcript, differential 
expression of both sense and antisense transcripts of the waaC, cgtB, cstII, wlaQA, and waaF 
genes under acid stress were examined using quantitative real-time RT-PCR. The results 
showed that when C. jejuni HB 93-13 was exposed to acid stress for 15 min, expression of 
both sense and antisense transcripts of each gene analysed were down regulated (Table 3.7). 
Therefore, these results showed that both sense and antisense transcripts of the waaC, cgtB, 
cstII, wlaQA, and waaF genes play a role in responsiveness of C. jejuni to acid stress.  
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DISCUSSION 
To my knowledge, this is the first description of bidirectional transcription of the LOS 
synthesis gene cluster from C. jejuni. The results indicated that both DNA strands of the LOS 
gene cluster serve as a template for mRNA synthesis, but transcription of the non-coding 
strands is at a lower rate. Furthermore, the results showed that both sense and antisense 
transcripts of each LOS gene examined are responsive to acid stress.  
Although multiple transcriptional start sites are observed throughout the LOS synthesis gene 
cluster, recognisable promoter regions are only located upstream of the most upstream 
initiation sites for the Cj1132c, waaC, cgtA, cgtB, cstII, wlaQA, and waaF genes (Table 3.5). 
Multiples start sites have also been observed for genes in Leishmania major Friedlin 
chromosome 1 (68) and the human type A gamma-aminobutyric acid receptor beta 1 subunit 
gene (90). In Neisseria gonorrhoeae, multiple start sites with multiple promoter sequences 
were also observed for the LOS-synthesis genes lgtABCDE, even for a single lgtD gene, and 
most of these promoters possessed
 
50 to 67% homology with the consensus gearbox promoter 
sequence
 
of E. coli (12). In C. jejuni, an initiation site 91 bp upstream of the start codon of the 
flagellar biosynthesis flhB gene was found using primer extension. However, no recognisable 
promoter sequence, like a typical σ
70
 or σ
28
 promoter, could be identified immediately 
upstream of this start site. Additional experiments using transcriptional flhB::lacZ reporter 
gene fusions showed that the flhB gene did have its own promoter, which was expressed at 
very low levels (69). Therefore, even though no promoter sequences could be identified in 
front of some of the initiation sites of the C. jejuni LOS genes, these sites could still be 
functional start sites. However, it could not be excluded that the additional initiation sites 
were a result of cleavage during RNA processing or RNA preparation, or premature 
termination of reverse transcription during the 5' RACE procedure. In addition, the 
identification of multiple start sites might also be a consequence of the lack of regulation of 
the polymerase enzyme during transcription and/or a very low specificity of the polymerase 
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(68, 70, 114); as a result, the transcription could initiate indiscriminately at several sites along 
the LOS gene cluster, and this could result in multiple transcripts for even a single LOS gene.  
Three crucial clones carrying gene junction regions in pMW10 could not be obtained. They 
were the reverse fragments Cj1132c/waaC and cgtB/cstII and the same orientation fragment 
wlaND/cgtA relative to the lacZ reporter gene. Even after multiple attempts no clones of 
pMW10 with these regions could be obtained. These missing clones might possess functional 
promoters since (i) multiple start sites on both DNA strands were observed in these regions 
and (ii) they showed a high similarity of DNA sequences to the wlaQA/waaF intergenic 
region, which exhibited bidirectional promoter activity in pMW10 in both forward and 
reverse directions (Table 3.6, 13.1A and 13.12A). 
The cloned wlaND/cgtA region contains a transcriptional start site with a potential promoter, 
however no promoter activity was observed. This could possibly be explained if (i) the cgtA 
gene is transcribed using a distal promoter(s) from another gene(s) as previously described for 
the C. jejuni fur gene (105), (ii) the identified start sites would be due to non-specific 
transcription as a result of low specificity of the polymerase (68, 70, 114), and (iii) this region 
possesses a very weak promoter, which could not be detected using the lacZ reporter gene 
system.  
The consensus sequence of the C. jejuni promoter contains three conserved regions, which are 
located approximately 10, 16, and 35 bp upstream of the transcriptional start site (115). The –
10 region consisting of 5'–TATAAT–3', which is very similar to that of a typical σ
70
 promoter 
of E. coli is conserved in C. jejuni as is also shown in this study (Table 3.5). However, the –
10 region of 5'–TAAAAT–3' is more predominant than that of 5'–TATAAT–3'. The –16 
region consisting of 5'–TTTTTTTG–3' is similar to that of a promoter found in Gram-positive 
bacteria. However, it is unlikely that this conserved region plays an important role, as a large 
number of homopolymeric tracts and a high A+T content are present in the genome of C. 
jejuni (81). The –35 regions of C. jejuni exhibit a high degree of variation and are different 
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from the –35 region of E. coli. This is also observed in this study (Table 3.5). Of these three 
promoter regions, the –10 region is likely to play the main role in C. jejuni promoter activity. 
Sequence comparison among the strand-switch regions in the genome of C. jejuni 11168 
(Cj1009c to Cj1289) (81) revealed a high similarity of DNA sequences for several regions. 
These included Cj1132c/waaC, cgtB/cstII, wlaQA/waaF, Cj1137c/Cj1138, Cj1166c/ldh, 
Cj1207c/Cj1208, Cj1237c/pdxJ, and gltX2/Cj1289. 
There are several possible explanations for bidirectional transcription of the LOS gene cluster. 
Firstly, there could be initiation sites with bidirectional promoters on both DNA strands in the 
strand-switch regions. This has also been observed in Leishmania major (46, 68) and was also 
shown in this study for the Cj1132c/waaC, cgtB/cstII, and wlaQA/waaF regions in C. jejuni. 
Secondly, there could be a lack of regulation of the polymerase enzyme during transcription 
and/or a very low specificity of the polymerase resulting in non-specific transcriptions (68, 
70, 114). This could explain why multiple start sites are observed throughout the LOS 
synthesis gene cluster even for a single gene with and without an active promoter. Thirdly, 
there might not be a tight control for transcription termination in the LOS gene cluster 
(waaC–waaF). In E. coli, it is well known that two major termination mechanisms, Rho-
independent and -dependent, are involved in transcription (113). To date, neither of these 
termination mechanisms have been experimentally demonstrated in the LOS gene cluster of 
C. jejuni. Analysis of the genome of E. coli showed that 567 Rho-independent transcription 
terminators are present (23), while only 9 are present in the genome of Helicobacter pylori 
(23), and 43 in the genome of C. jejuni NCTC 11168 (http://cmr.tigr.org/tigr-
scripts/CMR/CmrHomePage.cgi). Among these terminators in C. jejuni, two are present in the 
Cj1117 and Cj1173 genes, which are located outside the LOS gene cluster (81). This 
observation indicated that Rho-independent termination most likely does not occur in the LOS 
gene cluster. This could be supported by our results showing that a transcriptional linkage 
between operons occurred in the LOS genes (Fig. 3.2). Sturm et al have experimentally 
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shown that transcription can also be terminated by a T tract, which is commonly found in the 
3' end of all kinetoplastid SL RNA genes, and that more than six T’s are required for efficient 
termination in vivo (98). Possibly, this termination system may also be used by C. jejuni since 
a large number of homopolymeric T tracts are present in the genome of C. jejuni (81).  
This study also showed the physiological significance of both sense and antisense transcripts 
of some LOS genes for C. jejuni in response to acid stress. Differential expression is observed 
in the wlaII-LOS synthesis gene cluster. Under acid stress, the htrB expression is up regulated 
whilst expression of the waaC, cgtB, cstII, wlaQA, and waaF genes are down regulated. The 
reduction of expression of the waaC, cgtB, cstII, wlaQA, and waaF genes suggests a brief 
growth arrest. This allows
 
the cell to reshuffle energy and to devote this energy to an 
increased expression
 
of genes involved in a protective response and adaptation to the
 
new 
growth condition. This reduction reflects the energy-starved condition
 
of the cell and the 
necessity for saving and reshuffling energy
 
for the increased expression of proteins involved 
in preventing and repairing
 
damage caused by the acid downshift.  
Alain Stintzi previously examined the gene expression profile of C. jejuni 11168 under heat 
stress using microarray (97). Differential expression was observed for several genes in the 
wlaI-LOS (wla-MLKJIHGFEDCB, galE, and Cj1132c) synthesis gene cluster (81). Whereas 
the wlaE and galE genes were up regulated upon temperature increase, the wlaK gene was 
down regulated. As all genes in the wlaI-LOS gene cluster are translated in the same direction 
it would be expected that they would be similarly down or up regulated. However, this 
discrepancy suggests that the genes from the wlaI locus are transcribed as multiple operons 
using different promoters. A similar discrepancy was observed in this study for the waaC and 
htrB genes.  
It was found that the htrB gene is involved in regulating cell responses to various 
environmental changes including acid, heat, oxidative, and osmotic stresses (Chapter IV). 
This may be the reason why the htrB gene is independently regulated which would explain 
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why the transcription of its adjacent gene, waaC, shows a different response to environmental 
changes (Table 3.7).  
This present study showed bidirectional transcription of the LOS synthesis gene cluster from 
the GBS-associated C. jejuni strain HB 93-13. Both host and bacterial factors are expected to 
play an important role in GBS development (72, 103, 112). Some C. jejuni strains exhibiting 
human ganglioside-like LOS structures have a potential capacity to induce GBS (117). The 
LOS synthesis genes, which are essential for the formation of the GBS-inducible determinant, 
include galE (94), wlaND (Viraj N. Perera, unpublished data), cgtA (35, 37), cgtB (62), cstII 
(35), neuB (63), neuC (35), neuA (35), and waaF (76). Other bacterial factors, including phase 
variation (37, 62, 88), natural transformation (86), and bidirectional transcription as described 
in this study, have a potential effect on the expression of the GBS-inducible determinant. 
Since expression of some crucial genes cgtB, cstII, and waaF are down regulated under acid 
stress, further investigation of (i) gene regulation amongst GBS and non-GBS-associated C. 
jejuni strains and (ii) bacterial/environmental factors that up-regulate expression of the GBS-
inducible determinant will give a better insight into the pathogenesis of GBS. 
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CHAPTER IV 
Physiological examination of the pleiotropic functions of the LOS-synthesis 
htrB gene of C. jejuni HB 93-13 
 
 
 
 
 
 
 
The study described in this chapter was accepted for publication in 
 Microbiology, in press 
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ABSTRACT 
In Campylobacter jejuni, a htrB homologous gene is located in the lipooligosaccharide 
synthesis gene cluster. This study examined effects of htrB expression in responsiveness of S. 
typhimurium and C. jejuni to hash environments. Complementation experiment showed that 
the C. jejuni htrB gene could restore the normal morphology of the Salmonella htrB mutant 
and its ability to grow without inhibition in heat, acid, and osmotic stresses, but not bile stress. 
This indicated that the htrB genes in C. jejuni and S. typhimurium exhibit similar pleiotropic 
effects. Moreover, quantitative real-time RT-PCR showed that expression of the C. jejuni htrB 
gene was up regulated under acid, heat, oxidative, and osmotic stresses but it did not change 
under bile stress. This indicated that the C. jejuni htrB gene plays a role in regulating cell 
responses to various environmental changes. Furthermore, deletion mutation of the htrB gene 
in C. jejuni is lethal, indicating that the htrB gene is essential for C. jejuni survival. Therefore, 
these results showed that expression of the htrB gene is essential for responsiveness of S. 
typhimurium and C. jejuni to environmental stresses.  
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INTRODUCTION 
Modulation of lipid A acylation in Gram-negative bacteria results in pleiotropic effects. In 
Escherichia coli, mutation of the htrB gene encoding a lipid A acyltransferase leads to 
inhibition of bacterial growth at high temperature (49, 51), morphological change from short 
rods to filamentous rods (49), and unusually increased bile resistance (50). In Salmonella 
typhimurium, inactivation of the htrB homologous gene exhibits not only the same effects as 
seen in E. coli but also hyperflagellation and severely limited virulence (44, 100). In 
Haemophilus influenzae, knockout of the htrB gene resulted in an increased bile sensitivity 
(58), an increased sensitivity to human antimicrobial peptides (β-defensins) (95), a decreased 
colonisation capacity (101), a decreased intracellular viability (101), and a decreased pro-
inflammatory cytokine induction (104) but it does not affect morphology (58). In 
Campylobacter jejuni, the htrB gene is located in the wlaII-lipooligosaccharide (LOS) 
synthesis gene cluster and found to be conserved in this bacterium. Functionally, the C. jejuni 
htrB gene encodes a putative acyltransferase involved in lipid A synthesis (29, 32, 81). This 
study physiologically examined pleiotropic effects as a result of expression of the htrB gene 
of C. jejuni strain HB 93-13 using complementation, gene expression, and mutagenesis 
experiments. 
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MATERIALS AND METHODS 
Bacterial strains and growth conditions 
C. jejuni strains HB 93-13 (40), O:4, O:41, O:36, 81116 (78), NCTC 11168, ATCC 43446, 
and OH 4382 (3) were included in this study. C. jejuni was grown on Columbia agar plates 
supplemented with 5% (v/v) defribinated horse blood under microaerobic conditions (5% O2, 
10% CO2, and 85% N2) at 42˚C for 16 h unless otherwise stated. E. coli DH5α was grown in 
Luria-Bertani (LB) broth or agar at 37˚C for 16 h. The S. typhimurium strains SL1344 (wild 
type) and the SL1344 htrB1::Tn10 (htrB mutant, tetracycline resistance) were kindly provided 
by Dr. Bradley D. Jones, Department of Microbiology, University of Iowa, USA (44, 100).  S. 
typhimurium was grown in LB broth or agar at 30˚C for 16 h unless otherwise stated. Media 
were supplemented with ampicillin (150 µg/ml), µg kanamycin (15 or 50 µg/ml), tetracycline 
(20 µg/ml), 2% (w/v) X-Gal in dimethyl formamide (40 µl for each LB plate), and 100 mM 
IPTG (40 µl for each LB plate) when appropriate. 
Analysis of DNA and amino acid sequences 
Clone manager version 6 (Scientific and Education Software, USA) was used to design 
primers, plan cloning, and analyse DNA and amino acid sequences. Primers were designed 
using the wlaII-LOS synthesis gene cluster of C. jejuni strain HB 93-13 (accession no. 
AY297047) unless otherwise stated.  
DNA manipulation 
Plasmid DNA was isolated using the mini-prep procedure as previously described (6) and/or 
using the QIAprep spin miniprep kit (Qiagen) according to the manufacturer’s instructions. 
The DNA quantity was determined using a spectrophotometry. Restriction enzymes, T4 DNA 
ligase, and alkaline phosphatase were purchased from Promega and used according to the 
manufacturer’s instructions. Restriction mapping was performed to confirm the composition 
and size of the constructed plasmids by digestion with appropriate restriction enzymes. 
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Transformation of C. jejuni with plasmid DNA or genomic DNA was performed using 
electroporation (25 µF, 1.25 kV, and 600 Ω, gene pulser apparatus, Bio-Rad) and/or natural 
transformation (biphasic technique) as previously described (108). Transformation of E. coli 
and S. typhimurium with plasmid DNA was performed using electroporation (25 µF, 2.48 kV, 
and 200 Ω, gene pulser apparatus, Bio-Rad). Competent cells for E. coli and S. typhimurium 
were prepared in cold 10% (v/v) glycerol as previously described (91).  
pfu-PCR 
pfu-PCR was used to amplify a DNA fragment from purified chromosomal DNA. The 
reaction mixture was prepared in a 50 µl total volume of 1 × pfu buffer containing 200 µM of 
each dATP, dTTP, dCTP, dGTP, 100 ng of each primer, 100 ng of DNA, and 5 U of pfu 
polymerase (Roche). The PCR conditions were as follows: 94˚C for 3 min (initial 
denaturation); 35 cycles of 94˚C for 30 s (denaturation), 50˚C for 1 min (annealing), 72˚C for 
X min (extension); 72˚C for 7 min (final elongation). X was calculated by dividing the length 
of the PCR product by 500 bp as pfu polymerase synthesizes 500 bp per min. 
Colony-PCR 
Colony-PCR was used to screen transformants carrying new constructs. The reaction mixture 
was prepared in a 50 µl total volume of 1 × Taq buffer containing 1.5 mM of MgCl2, 200 µM 
of each dATP, dTTP, dCTP, dGTP, 100 ng of each primer, and 2.5 U of Taq polymerase 
(ABI). A tip of 200 µl in size was used to gently touch a colony on culture plate and directly 
mixed into the PCR tube containing the master reagent, which had been already prepared. The 
PCR conditions were as follows: 94˚C for 10 min; 35 cycles of 94˚C for 30 s, 50˚C for 1 min, 
72˚C for Y min; 72˚C for 7 min. Y was calculated by dividing the length of the PCR product 
by 1000 bp as Taq polymerase synthesises 1,000 bp per min. 
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Construction of plasmid carrying the C. jejuni htrB gene in the S. typhimurium htrB 
mutant 
A 917-bp DNA fragment containing 18 bp of the waaC gene (upstream adjacent gene), the 
entire htrB gene (888 bp), and 11 bp of the wlaNC gene (downstream adjacent gene) of C. 
jejuni strain HB 93-13 was amplified by pfu-PCR with primers BamHI-waaC-F (5'-
TTGCCAAAGGATCCCTTAATGAAAAATAGTGATAG-3') and ClaI-wlaNC-R (5'-
TTGTTATCGATTCATTTTGCACCCTTGT-3'). A PCR product was cloned into the 
pBluescript plasmid in the same orientation as the ampicillin resistance cassette using the 
BamHI and ClaI sites, and the resultant construct was subsequently introduced into E. coli 
DH5α by electroporation. Transformants carrying the htrB gene constructs were screened 
using colony-PCR with primers 172-pBlue-F (5'-GGTTCCGATTTAGTGCTTTA-3') and 
825-pBu-R (5'-GAAACAGCTATGACCATGAT-3'). These primers were designed to amplify 
a 1516-bp plasmid fragment, which included a 917-bp inserted PCR product. The pBluescript 
carrying the C. jejuni htrB gene (named pBlue htrB+) was isolated from E. coli and then 
introduced into the S. typhimurium htrB mutant by electroporation.  
Examination of bacterial growth and morphology 
The wild type, mutant, and complemented Salmonella strains were grown on LB agar plates 
at 30, 37, and 42˚C for 24 h to an OD600 of 0.3. The culture media were supplemented with 
appropriate antibiotics. Tetracycline was added to growth media used for the S. typhimurium 
mutant, while ampicillin and tetracycline were added into the growth media used for the 
complemented strain. The ability of bacteria to grow at 30, 37, and 42ºC temperatures was 
observed. A Gram stain was performed and the morphology was observed under a light 
microscope. 
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Examination of bacterial sensitivity to acid and osmotic stresses 
To test for acid sensitivity, the wild type, mutant, and complemented Salmonella strains 
(OD600 at 0.3) were grown at 30ºC in 0.1% (w/v) peptone water, ranging from pH 2.5 to 7.0 
for 24 h. After incubation, the cell density was measured at OD600, and an equal volume of 
cultured medium was distributed on LB agar plates. All culture media were supplemented 
with appropriate antibiotics as previously described. The plates were incubated at 30ºC for 
another 24 h. To test for osmotic sensitivity, again the bacteria were grown as previously 
described, except that 0.1% peptone water (pH 7.0) was supplemented with NaCl (1 to 10% 
w/v). 
Examination of bacterial sensitivity to bile stress 
To test for bile sensitivity, the wild type, mutant, and complemented Salmonella strains 
(OD600 at 0.3) were grown on LB agar plates containing sodium deoxycholate (DOC; 2, 4, 6, 
8, and 10%). The culture media were supplemented with appropriate antibiotics as previously 
described. The plates were incubated at 30ºC for 24 h. 
Treatment of C. jejuni with stress environments and RNA preparation 
Prior to the treatment of C. jejuni with stress environments, the ability of C. jejuni HB 93-13 
to grow in brucellar broths under heat, acid, osmotic, oxidative, or bile condition was 
examined. A growth temperature of 44ºC was selected as heat stress since C. jejuni was able 
to grow at 43ºC but not 45ºC. A pH of 5.5 was selected as acid stress since C. jejuni showed 
normal growth at pH 6.0, inhibited growth at pH 5.5, and no growth at pH 5.0. A NaCl 
concentration of 1.5% was selected as osmotic stress since the bacteria showed normal growth 
at 1% NaCl, inhibited growth at 1.5% NaCl, and no growth at 2% NaCl. For a C. jejuni was 
unable to grow in normal atmospheric conditions this was used for the oxidative stress 
challenge. For bile stress, 500 µg/ml of DOC was considered as bile stress (61).  
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C. jejuni HB 93-13 was grown in 30 ml of brucella broth with gentle shaking under 
microaerobic conditions at 37ºC for 19 h, and 100 µl of bacterial culture was aliquoted into 6 
bottles of brucella broth (30 ml) and incubated for another 19 h. After incubation, 1 ml of 
brucella broth, which had been supplemented with concentrated HCl, NaCl, or DOC and pre-
warmed at 37ºC, was added to culture bottles to obtain a final pH of 5.5 (acid stress), a NaCl 
concentration of 1.5% (osmotic stress), and a DOC concentration of 500 µg/ml (bile stress). 
The fourth culture bottle was added with 1 ml of pre-warmed brucella broth and used as the 
calibrator (normal htrB expression level). The fifth culture bottle was immediately moved to 
the 44ºC incubator (heat stress). The incubation was performed at 37ºC, except the fifth 
culture bottle, with gentle shaking under microaerobic conditions. The bacteria from the sixth 
culture bottle was poured onto culture plate and incubated at 37ºC with gentle shaking under 
normal atmospheric conditions (oxidative stress). Culture samples were collected after 
incubation for 15 min and 30 min and transferred directly into a 1/10 volume of cold 10 × 
stop solution [5% (v/v) phenol in 100% ethanol] to halt transcription and RNA degradation. 
RNA samples were isolated using the RNAgents total RNA isolation system (Promega), and 
DNA decontamination was performed using the TURBO DNA-free Kit (Ambion).  
Quantitative real-time RT-PCR 
Primers used for cDNA synthesis were as follow. The primers q-htrB-R (5'-
TTGAGTGTATTGAGGAAAAC-3'), q-16S rRNA-R (5'-GTATTCTTGGTGATATCTAC-3', 
accession no. AL111168), q-luxS-R (5'-ATAAATCCTGCGAATAAATG-3', accession no. 
AL111168), or q-rpoA-R (5'-ATTTGTCCATCAGTTGTTAC-3', accession no. AL111168) 
were used for synthesis of cDNA for the htrB, 16S rRNA, luxS, or rpoA genes, respectively.  
The cDNA synthesis was performed using the ImProm-II reverse transcriptase (Promega). 
One microgram of RNA and 50 ng of anti-sense primer in a total volume of 5 µl was heated at 
70°C for 5 min and immediately chilled on ice for at least 5 min. The master mix was 
prepared in a total volume of 15 µl, which consisted of 5 µl of RNase-free water, 4 µl of 
 99
ImPorom-II 5 × reaction buffer, 2 µl of MgCl2 (25 mM), 1 µl of dNTP mix (10 mM each 
dNTP), 2 µl of recombinant RNasin ribonuclease inhibitor (5 u/µl), and 1 µl of Improm-II 
reverse transcriptase (1 µl/reaction). The master mix was dispensed into the reaction tube 
containing the mixture of heated RNA and primer. The tube was gently mixed and followed 
by incubation at 25°C for 5 min, 42°C for 60 min, and 70°C for 15 min. Reverse transcriptase 
was substituted by RNase-free water for the negative control. After cDNA synthesis, the 
reaction mixture was added with 10 µl of RNase A solution (20 µg/ml), incubated at 37°C for 
20 min, and added with 220 µl of water. For each gene, dilution series of newly synthesised 
cDNA were made and included in a quantitative PCR to examine the efficiency of PCR.  
Primers used for PCR were as follows. The primers q-htrB-F (5'-
TTATGCCTGATTGTATCTTG-3') and q-htrB-R as previously described were used to 
amplify a 125-bp fragment of the htrB gene-specific cDNA. The primers q-16S rRNA-F (5'-
GTCTCTTGTGAAATCTAATG-3', accession no. AL111168) and q-16S rRNA-R as 
previously described were used to amplify a 123-bp fragment of the 16S rRNA gene-specific 
cDNA. The primers q-luxS-F (5'-AAGTTATGAAAACACCTAAG-3', accession no. 
AL111168) and q-luxS-R as previously described were used to amplify a 124-bp fragment of 
the luxS gene-specific cDNA. The primers q-rpoA-F (5'-GCTTTAGATGCTTTCTTTAC-3', 
accession no. AL111168) and q-rpoA-R as previously described were used to amplify a 119-
bp fragment of the rpoA gene-specific cDNA. 
A quantitative PCR was performed on the MyiQ (Bio-Rad) using iQ SYBR Green Supermix 
(Bio-Rad) according to the manufacturer’s instructions. The PCR reaction was performed in a 
total volume of 25 µl, which contained 12.5 µl of iQ SYBR Green Supermix and 12.5 µl of 
master mix consisting of 1 µl of forward primer (50 ng/µl), 1 µl of reverse primer (50 ng/µl), 
3 µl of diluted cDNA, and 7.5 µl of water. Each PCR was performed in duplicate. The same 
PCR samples that showed variant values of the cycle threshold (CT) of more than 1 were 
repeated. PCR conditions were as follows: cycle 1 (1×): 95°C for 5 min; cycle 2 (35×): 95°C 
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for 30 s, 55 or 60°C for 30 s (55°C for luxS; 60°C for htrB, 16S rRNA, and rpoA), 72°C for 30 
s; cycle 3 (100×): 95°C for 10 s (decrease setpoint temperature after cycle 2 by 0.5ºC, and 
enable melt curve data collection and analysis). Each specific amplicon was verified both by 
the presence of a single melting temperature peak and by the presence of a single band of 
expected size on a 3% agarose gel after electrophoresis. Cycle threshold values were 
determined with the MyiQ software (Bio-Rad). The relative changes (X-fold) in gene 
expression between the induced and calibrator samples were calculated using the 2
-∆∆CT
 
method as described by Livak and Schmittgen (64). The 16S rRNA, rpoA, and/or luxS genes 
were used as the internal controls. A relative expression value of more than 2 fold was 
considered significant as up or down regulation.  
Construction of the C. jejuni htrB mutant 
The pBluescript plasmid carrying the mutated htrB gene of C. jejuni HB 93-13 was 
constructed. Firstly, a 646-bp DNA fragment containing the partial waaC and htrB genes of 
C. jejuni HB 93-13 (nucleotide 140-785, AY297047) was amplified by the pfu-PCR with 
primers EcoRI-waaC-F1 (5'-ATAGGAATTCATAGCGGTCCAACACA-3') and BamHI-
htrB-R1 (5'-AATCGGATCCTATTTAGCCGCATAAGC-3'). The PCR product was cloned 
into the pBluescript plasmid in the forward direction via the EcoRI and BamHI sites. The 
resultant construct was subsequently introduced into E. coli DH5α by electroporation. A 
positive clone was selected on LB agar supplemented with ampicillin, X-gal, and IPTG 
according to the blue and white phenotypes. This procedure identified the pBluescript 
carrying the partial waaC and htrB genes (named pBluA). Secondly, the pfu-PCR with 
primers BamHI-htrB-F2 (5'-TTACGGATCCAGACTGCGTAGAAAACGA-3') and XbaI-
wlaNC-R2 (5'-CCTTTCTAGAGATTTTTACGGCTAAGTG-3') was used to amplify a 678-
bp DNA fragment containing the partial htrB and wlaNC genes (nucleotide 934-1611, 
AY297047). This PCR product was cloned into pBluA in the forward orientation via the 
BamHI and XbaI sites. Positive clones were identified by colony hybridisation using the 
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second PCR product, labelled with digoxigenin using the DIG labelling kit (Roche), as probe. 
The colony-DNA probe hybridisation was performed at 65˚C overnight, and detection was 
performed using the alkaline phosphate-conjugated anti-DIG antibody and the NBT/BCIP 
substrate as described in the user’s guide handbook (Roche). Positive clones carrying the htrB 
gene with a 150 bp (nucleotide 785 to 934) deletion were named pBluB. A 1,494-bp 
kanamycin resistance cassette (Km) was cloned into the pBluB using the BamHI site. This 
resulted in a construct containing part of the htrB gene interrupted by the Km (named pBluC) 
in which the Km was flanked by a 646-bp upstream DNA fragment and a 678-bp downstream 
DNA fragment. The pBluC carrying the Km in the same direction as the htrB gene was named 
pBluCF, while the construct carrying the Km in the opposite direction to the htrB gene was 
designated pBluCR. Finally, these constructed plasmids were confirmed by sequencing using 
the ABI sequencing mix V3.1 (ABI) according to the manufacturer’s instructions.  
Natural transformation and electroporation were used to introduce each recombinant plasmid 
(pBluCF and pBluCR) into C. jejuni strains HB 93-13, O:4, O:41, O:36, 81116, 11168, 
ATCC 43446, and OH 4382. The pBluescript plasmid carrying the Km within the wlaVA gene 
(pBlu11KR) or the waaF gene (pBlu13KF) were used as the positive controls. The 
pBluescript alone was used as the negative control. Transformants were screened on 5% 
blood agar plates supplemented with kanamycin (15 µg/ml). Culture media were incubated 
under microaerobic conditions at 30, 37, and 42˚C for 5 days. 
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RESULTS AND DISCUSSION 
Characteristics of the C. jejuni htrB gene  
The htrB homologue of C. jejuni HB 93-13 is located in the wlaII-LOS synthesis gene cluster. 
DNA sequence analysis of the C. jejuni htrB gene showed an open reading frame of 888 bp 
initiating with a methionine when translated. Under microaerobic conditions, the htrB gene 
and the other LOS synthesis genes were transcribed as part of several operons using multiple 
transcriptional start sites with promoters upstream of the start codons of the Cj1132c, waaC, 
cgtA, cgtB, cstII, wlaQA, and waaF genes (Chapter 3). Multiple sequence alignments showed 
that the C. jejuni HB 93-13 HtrB protein was similar to the E. coli HtrB (20%, accession no. 
NC_004431), the S. typhimurium HtrB (20%, NC_003197), and the H. influenzae HtrB (20%, 
NC_000907) proteins. Among other bacteria, the S. typhimurium HtrB showed 78% similarity 
to the E. coli HtrB and 54% similarity to the H. influenzae. These results showed that S. 
typhimurium, E. coli, and H. influenzae HtrB proteins were closer related to each other than to 
the C. jejuni HtrB protein. In S. typhimurium, mutation of the htrB gene, which encodes for an 
acyltransferase enzyme involved in lipid A synthesis, resulted in pleiotropic effects in both 
pathology and physiology of S. typhimurium. These effects included morphological changes 
from short rods to filamentous rods, hyperflagellation, inability to grow at high temperatures, 
increased bile resistance, and reduced virulence (44, 100). In this study, the S. typhimurium 
htrB mutant was used as the model for studying pleiotropic effects as a result of expression of 
the C. jejuni htrB gene. The S. typhimurium htrB mutant was complemented with the htrB 
gene from C. jejuni HB 93-13. The wild type, mutant, and complemented Salmonella strains 
were characterised. 
The role of the C. jejuni htrB gene in S. typhimurium morphology 
To examine whether expression of the C. jejuni htrB gene affected the morphology of the S. 
typhimurium htrB mutant, the wild type, mutant, and complemented Salmonella strains were 
grown on LB agar plates at 30, 37, and 42ºC for 24 h. The culture media were supplemented 
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with appropriate antibiotics. A Gram stain was performed and the morphology was observed 
under a light microscope. The morphology of the complemented and wild type strains was 
similar showing Gram-negative short rods at 30, 37, and 42ºC, while the morphology of the 
mutant was Gram-negative filamentous, bulgy, and short rods at all temperatures tested (Fig. 
4.1a). These results showed that the C. jejuni htrB gene could restore the wild-type 
morphology of the S. typhimurium htrB mutant, and hence its expression affected the bacterial 
morphology.   
The role of the C. jejuni htrB gene in growth of S. typhimurium at high temperature 
To examine whether expression of the C. jejuni htrB gene affected the capacity of bacteria to 
grow at high temperature, the wild type, mutant, and complemented Salmonella strains were 
grown on LB agar plates as previously described. The results showed that the C. jejuni htrB 
gene could restore the ability of the S. typhimurium htrB mutant to grow at high temperatures 
as the complemented and wild type strains grew normally at 30, 37, and 42ºC, while the 
mutant was temperature sensitive and showed inhibited growth at 37 and 42ºC (Fig. 4.1b). 
This showed that the C. jejuni htrB gene is essential for the S. typhimurium htrB mutant to 
grow properly at high temperature. A previous study showed that the S. typhimurium htrB 
mutant was unable to grow at 37ºC (100) while in this study this bacterial strain showed 
inhibited growth at 37ºC (Fig. 1b). These inconsistent results could possibly be explained by a 
loss of temperature sensitivity of the S. typhimurium htrB mutant after a few passages at 30ºC, 
which was also observed for the H. influenzae htrB mutant (58).    
The role of the C. jejuni htrB gene in acid sensitivity of S. typhimurium 
To examine whether expression of the C. jejuni htrB gene affected the acid sensitivity, the 
wild type, mutant, and complemented Salmonella strains were grown at 30ºC in 0.1% (w/v) 
peptone water (pH 2.5 to 7.0) for 24 hours. After incubation, the cell density was measured at 
OD600, and an equal volume of culture medium was distributed on LB agar plates. All culture  
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Figure 4.1. Complementation experiments. WT, wild type S. typhimurium strain SL1344; M, 
S. typhimurium htrB mutant; C, S. typhimurium htrB mutant carrying the functional htrB gene 
from C. jejuni HB 93-13; (a), morphology at different temperatures; (b), ability of bacteria to 
grow at high temperatures; (c), ability of bacteria to grow in high acidity; and (d), ability of 
bacteria to grow in high osmolality. 
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media were supplemented with appropriate antibiotics as previously described. The plates 
were incubated at 30ºC for another 24 h. The results showed that the mutant strain exhibited 
less growth on LB agar plates compared to the wild type and the complemented strain showed 
intermediate growth between the wild type and mutant strain at lower pH (Fig. 4.1c, selected 
results of bacterial growth on LB plates). Therefore, expression of the C. jejuni htrB gene 
contributed to the acid tolerance of the S. typhimurium htrB mutant. 
The role of the C. jejuni htrB gene in high osmotic sensitivity of S. typhimurium 
To examine whether expression of the C. jejuni htrB gene affected the osmotic sensitivity, the 
wild type, mutant, and complemented Salmonella strains were grown as previously described 
in acid sensitivity assay, except that 0.1% peptone water (pH 7.0) was supplemented with 
NaCl (1 to 10%). The complemented and wild type strains exhibited a similar growth, while 
the mutant showed inhibited growth (Fig. 4.1c, selected result). Therefore, the results showed 
that expression of the C. jejuni htrB gene contributed to the osmotic resistance of the S. 
typhimurium htrB mutant.  
The role of the C. jejuni htrB gene in bile sensitivity of S. typhimurium 
To examine whether expression of the C. jejuni htrB gene affected the bile sensitivity, the 
wild type, mutant, and complemented Salmonella strains were grown on LB agar plate 
supplemented with DOC concentrations of 2, 4, 6, 8, and 10%. The results showed that the C. 
jejuni htrB gene could not complement the bile sensitivity of the S. typhimurium htrB mutant 
as the mutant and complemented strains were able to grow in all DOC concentrations tested, 
while the wild type strain was able to grow in DOC up to 8%. Similarly, a bile-resistant 
phenotype of the S. typhimurium htrB mutant was also observed by Sunshine et al. (100). 
However, the study of bile sensitivity in other bacteria showed inconsistent results. The H. 
influenzae htrB mutant was more bile-sensitive than the wild type strain (58), while the E. coli 
htrB mutant was more bile-resistant than the wild type strain (50, 100). Since expression of 
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the C. jejuni htrB gene did not affect the bile sensitivity of the S. typhimurium htrB mutant, 
the C. jejuni htrB gene might not have a role in the bile sensitivity in C. jejuni. 
Expression of the htrB gene in C. jejuni under stress environments 
To examine whether stress environments, including heat, acid, osmotic, oxidative, and bile 
stresses affected expression of the htrB gene in C. jejuni, quantitative real-time RT-PCR was 
performed. Before the quantitative data were accepted, three criteria were required. Firstly, no 
PCR product should be detected from the negative control without reverse transcriptase, 
confirming the lack of DNA contamination in the RNA sample. Secondly, PCR efficiency for 
each gene should be at least 80%. This ensured that low amounts of PCR product were due to 
low expression levels of the genes of interest, not because of low PCR efficiency. Thirdly, 
only one peak for each gene analysed should be observed in the melting curve, confirming the 
lack of non-specific PCR product. In this study, the rpoA gene encoding the alpha subunit of 
RNA polymerase and the 16S rRNA gene encoding the 16S rRNA subunit (81) were used as 
the internal negative controls, and it was expected that their expressions should not be 
affected by change of environments. The luxS or Cj1198 (81), which produces the 
autoinducer-2 involved in quorum sensing (21), was used as the internal positive control, and 
its expression should be affected by change of environments. The results showed that there 
was no ideal and universal internal positive/negative control. For example, after C. jejuni was 
exposed to stress environments for 15 min, expression of the luxS gene was not affected under 
heat and bile stresses but it was affected under other environments. Expression of the 16S 
rRNA gene showed a lesser variation under osmotic and oxidative stresses but it showed a 
higher variation under other environments when compared to other genes  (Table 4.1). As a 
result, for each environment, expression of the control gene that showed lowest variation was 
selected as the internal control. Therefore, at 15 min, the rpoA gene was selected as the 
internal control for studying the htrB expression under acid stress, the luxS gene was used as 
the control under heat and bile stresses, and the 16S rRNA gene was selected as the control 
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Table 4.1. Expression of the C. jejuni htrB gene under stress environments 
CT of genes 
Condition  
htrB 16S  luxS rpoA 
∆CT 
calibrator
a
 
∆CT 
htrB
b
 
∆∆CT
c
 2
–∆∆CT d
 
At 15 min 
Normal 
Acid  
Bile  
Osmotic  
Heat  
Oxidative  
At 30 min 
Normal  
Acid  
Bile  
Osmotic  
Heat  
Oxidative  
 
26.06 
20.34 
25.53 
23.32 
23.32 
20.35 
 
20.49 
18.39 
20.32 
21.02 
20.75 
19.03 
 
11.33 
10.58 
7.88 
9.83 
8.58 
8.37 
 
10.31 
9.68 
9.81 
10.03 
8.60 
10.12 
 
31.63 
29.6 
31.29 
29.44 
31.13 
25.94 
 
28.10 
28.59 
29.98 
26.38 
29.39 
26.03 
 
24.24 
24.00 
ND 
ND 
ND 
19.51 
 
21.07 
ND 
ND 
ND 
21.70 
20.81 
 
 
–1.82 
5.57 
–14.73 
5.57 
–14.73 
 
 
7.61 
–10.18 
–10.18 
0.58 
–10.18 
 
 
3.66 
5.76 
–13.49 
7.81 
–11.98 
 
 
10.20 
–10.51 
–10.99 
0.95 
–8.91 
 
 
–5.48 
–0.19 
–1.24 
–2.24 
–2.75 
 
 
–2.59 
0.33 
0.81 
–0.37 
–1.27 
 
 
44.63 
1.14 
2.36 
4.72 
6.73 
 
 
6.02 
–1.26 
–1.75 
1.29 
2.4 
ND, not determined; CT, cycle threshold value; underline, CT value of the internal control 
genes that did not change or slightly affected by change of environments, these genes were 
selected as the internal controls under particular environments. For example, at 15 min, the 
rpoA gene was used as the control gene under acid stress as its expression (CT) was not 
affected by acid stress (24.00 versus 24.24 under normal conditions. 
a
, ∆CT calibrator was calculated by subtracting the CT value of the control gene under normal 
conditions from the CT value of the htrB gene under normal conditions. 
b
, ∆CT htrB was calculated by subtracting the CT value of the control gene under stress from 
the CT value of the htrB gene under the same stress. 
c
, ∆∆CT was calculated by subtracting the value of the ∆CT calibrator from the value of the 
∆CT htrB. 
d
, 2
–∆∆CT
 > 2, gene expression was up regulated; 2
–∆∆CT
 < –2, gene expression was down 
regulated; –2 ≥ 2
–∆∆CT
 ≤ 2, gene expression was not affected by change of environments.  
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under oxidative and osmotic stresses. At 30 min, the luxS and rpoA genes were selected as the 
control genes under acid and heat stresses, respectively. The 16S rRNA gene was selected as 
the control gene under oxidative, bile, and osmotic stresses. After the expression level of the 
hrtB gene was subtracted with that of the internal control, it was found that after C. jejuni was 
exposed to each artificial environment for 15 min, expression of the htrB gene was highly up 
regulated under acid stress, moderately up regulated under heat and oxidative stresses, slightly 
up regulated under osmotic stress, and did not change under bile stress. After 15 min
 
of 
exposure, its expression gradually decreased
 
with time to reach/close to a baseline level at 30 
min. At this time point, expression of the htrB gene was moderately up regulated under acid 
stress, slightly up regulated under oxidative stress, and did not change under bile, osmotic, 
and heat stresses (Table 4.1). These results showed that the C. jejuni htrB gene is involved in 
regulating cell responses to various environmental changes. This is consistent with our 
previous results that the C. jejuni htrB gene is essential for the S. typhimurium htrB mutant to 
grow at high temperatures, acidity, and osmolality. 
The results of the real-time RT-PCR experiments showed that expression of the C. jejuni htrB 
gene was up regulated under harsh environments, including heat stress. In contrast, a previous 
study showed that expression of the E. coli htrB gene was not affected by heat-shock using 
Northern blot analysis (51). It was proposed that the E. coli htrB gene is a member of a new 
class of genes whose products are required for growth at high temperature but are not heat 
shock genes (50). Similarly, expression of the htrB gene of C. jejuni NCTC 11168 was not 
significantly up or down regulated after the growth temperature had been shifted from 37 to 
42ºC using microarray analysis (97). The cause for this inconsistent result might be due to the 
sensitivity of the methods used. According to the results presented in this study and the fact 
that real-time RT-PCR is the most sensitive method for differential gene expression, therefore 
expression of the C. jejuni htrB gene is affected by heat-shock. 
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Effect of modulation of lipid A acylation in C. jejuni 
To examine the effect of modification of lipid A acylation in C. jejuni, the acyltransferase-
encoding htrB homologous gene was inactivated using mutagenesis experiments. Firstly, two 
recombinant pBluescript plasmids were constructed. The first construct carried the Km within 
the htrB gene in the same orientation (pBluCF). The second construct carried the Km in the 
reverse orientation to the htrB gene (pBluCR). Secondly, natural transformation and electro-
transformation were used to transform various C. jejuni strains with these constructs. 
Plasmids carrying a Km within the wlaVA gene (pBlu11KR) and within the waaF gene 
(pBlu13KF) were used as the positive controls. The pBluescript without insert was used as the 
negative control. Transformants were screened on a selective media that was supplemented 
with a low concentration of kanamycin (15 µg/ml) since the H. influenzae htrB mutant was 
previously shown to be hypersensitive to kanamycin (58). The culture media were incubated 
at 30, 37, and 42ºC for 5 days since a previous study showed that the E. coli htrB mutants 
could not initially grow on rich media at temperatures above 33ºC (49). As expected, a 
number of C. jejuni waaF and wlaVA mutants were obtained from the positive controls, and 
no transformants were recovered from the negative control. This showed that the possibility 
that different restriction modification systems between C. jejuni and E. coli would be a barrier 
for interstrain plasmid transfer could be ruled out. No transformants carrying the mutated htrB 
gene as a result of homologous recombination via a double cross over event were recovered 
on the selective medium. However, a few transformants carrying both an intact and a mutated 
htrB gene resulting from a single cross-over were observed. After several passages of these 
transformants and after transformant-derived genomic DNA was introduced into the parental 
C. jejuni strain HB 93-13, individual progenies still carried both mutated and intact htrB 
genes (results not shown). These results indicated that the htrB gene is essential for C. jejuni 
survival and hence gene deletion in C. jejuni causes loss of cell viability. 
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A previous study showed that the plasmid transformation frequency via homologous 
recombination directly correlates with the size of the flanking regions (108). DNA 
recombination between the inserts present in suicide vectors and the genome occurred with as 
little as 200 homologous base-pairs present (108). The plasmids pBluCF and pBluCR carried 
the Km flanked by a 646-bp upstream region consisting of the partial waaC and htrB genes 
and a 678-bp downstream region consisting of the partial htrB and wlaNC genes. Therefore 
the sizes of these flanking regions should have been sufficient to initiate homologous 
recombination in C. jejuni.  
The possible explanations why the htrB gene could be mutated in other bacteria but not in C. 
jejuni are as follows. Firstly, unlike most other bacteria C. jejuni is a fragile enteric bacterium. 
For example, it was found that the growth of C. jejuni was not observed in brucella broth with 
NaCl > 1.5%, DOC > 2% or pH < 5.5. In addition, C. jejuni is hypersensitive to normal 
atmospheric conditions. In contrast, the growth of S. typhimurium was still observed in a 
medium consisting of 10% NaCl, 10% DOC, or pH 3.0, and it was able to grow under normal 
atmospheric consitions. Secondly, the results of the complementation and gene expression 
presented here indicated that the C. jejuni htrB gene is involved in morphology (cell wall 
formation) and is essential for growth under stress environments, including acid, heat, 
osmotic, and oxidative stresses. Thirdly, accomplishment of inactivation of the htrB genes 
might depend on the mutagenesis-based techniques. In this study, deletion mutation was 
approached to inactivate the htrB gene in C. jejuni (see method). Several attempts were made 
without success. In contrast, insertional mutagenesis of the htrB genes using transposon-based 
technique was successful in S. typhimurium (100), E. coli (49), and H. influenzae (58). 
Similarly, deletion mutation of the waaC gene, which is located upstream of the htrB gene, 
resulted in loss of viability of C. jejuni strain 81116 (Benjamin N. Fry, unpublished data), 
while insertion mutation of the waaC homologous gene in C. jejuni strain 81-176 was 
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successful (45). Therefore, deletion mutation of the C. jejuni htrB gene might result in cell 
wall dysfunction, such as loss of membrane permeability, leading to bacterial cell death. 
The role of the C. jejuni htrB gene in lipid A synthesis is controversial. A number of previous 
studies have proposed that the C. jejuni htrB gene encodes a putative acyltransferase involved 
in lipid A synthesis (32, 81). Since bile is responsible for digesting fats by disaggregating the 
lipid bilayer of the cellular membrane, inactivation of the lipid A-synthesis gene should 
increase the bile sensitivity of bacterial cells. Generally, if the C. jejuni htrB gene has a role in 
lipid A synthesis, its expression should be affected under bile stress. This study indicated that 
the htrB gene might not play a role in lipid A synthesis since its expression did not change 
when C. jejuni was exposed to bile stress. Additionally, it could not complement the bile 
sensitivity of the S. typhimurium htrB mutant. As the role of the S. typhimurium htrB gene in 
lipid A synthesis could be demonstrated by mass spectrometric analysis of the crude lipid A 
fraction, this technology could possibly also be used to analyse the C. jejuni htrB gene and its 
role in lipid A synthesis.  
 
 
 
 
 
 
 
 
 
 
 112
CONCLUSION 
This study showed that (i) expression of the C. jejuni htrB gene is essential for responsiveness 
of S. typhimurium to stress environments, (ii) the C. jejuni htrB gene involves in regulating 
cell responses to environmental changes, and (iii) it is likely that the htrB gene is essential for 
C. jejuni survival. 
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GENERAL DISCUSSION AND FUTURE DIRECTION 
In this study, insights into the lipooligosaccharide (LOS) synthesis genes in relation to 
pathophysiology of C. jejuni were made. These included mechanisms contributing to diversity 
of LOS genes (Chapter I), physiological properties of DNA/RNA (Chapter II), unusual 
transcription of LOS genes (Chapter III), and pleiotropic effects of the LOS molecule 
(Chapter IV). 
Polymorphism is considered as a major trait of C. jejuni. This genetic variation provides a 
population with genome plasticity that contributes to the adaptation and survival of this 
bacterium in hostile environments. Molecular epidemiological analysis suggests that C. jejuni 
has a largely non-clonal population structure, and genotype diversity is generated 
continuously (22). A number of genetic mechanisms have been proposed which contribute to 
the genetic diversity including horizontal transfer of genes within and between bacterial 
populations (Chapter I) (7, 11, 30, 86) and intragenomic events such as rearrangements, point 
mutations, deletions, duplications, inversions, and phase variation (1, 32, 37, 62, 88, 110). 
These events explain the genome plasticity, including the diversity of the LOS synthesis gene 
clusters, in C. jejuni.  
Instability of the C. jejuni LOS gene cluster limits current typing systems. Currently, 
there are two LOS-based typing systems, the Penner serotyping system (85) and the LG 
typing system (92). The Penner system is based on antibodies to LOS and/or capsule (48), 
while the LG typing system is based on PCR-RFLP patterns of the wlaI-LOS synthesis gene 
cluster. Generally, it is assumed that typing systems should be based on traits that exhibit 
diversity and stability. In C. jejuni, the LOS structures reveal diversity among strains as a 
result of horizontal gene transfer within and between strains (Chapter I) (7, 11, 30, 86) and 
phase variation (37, 62, 88). However, the LOS structure is not stable as certain strains, like 
C. jejuni 81116, can change their entire LOS gene clusters as well as their LOS structures 
following natural transformation (Chapter I). Therefore, LOS based typing systems are not 
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ideal and the search for better traits to be used for typing of C. jejuni strains should be 
continued.  
C. jejuni DNA or RNA has different physiological properties to that of other bacteria. 
While attempting to analyse transcription of the LOS synthesis gene cluster, it was observed 
that obtaining a DNA-free RNA sample from C. jejuni proved difficult. Many RNA methods 
were tried on their own or in combination and a DNA-free RNA sample could only be 
obtained using a combination of RNAzolB, TURBO DNAse treatment, and acid phenol 
extraction. The removal of contaminating DNA from an RNA sample seemed especially 
difficult for RNA isolated from C. jejuni. For example, 10 µg of genomic DNA isolated from 
E. coli DH5α could be completely eliminated by treatment with DNase for 1 hour. In contrast, 
DNase treatment of a C. jejuni RNA sample was not successful although the same RNA 
sample was repeatedly treated with DNase. This observation indicated the possibility that (i) 
bacterial factors, such as the methylation system, contribute to the tolerance of C. jejuni DNA 
to DNase, and (ii) DNase enzymes used in this study possess a low specificity to C. jejuni 
DNA. Thus, further investigations of (i) the association between the methylation system and 
expression of the LOS synthesis genes and (ii) a comparative functional study between C. 
jejuni DNase and other bacterial DNases may unravel the mechanism behind this 
phenomenon. Moreover, two patterns of total RNA were observed for different C. jejuni 
strains. Some strains exhibited a normal RNA pattern showing three separate bands, 
corresponding to 23S rRNA, 16S rRNA, and 5S rRNA, as found in other Gram-negative 
bacteria. In contrast, the RNA pattern of most C. jejuni strains tested revealed four bands. It 
seems likely that the 23S rRNA fragment is cleaved resulting in two molecules, one larger 
and one smaller than the 16S rRNA. Again, further characterisation of the 23S rRNA 
genes/proteins may unravel its particular role in relation to the pathophysiology of C. jejuni.  
The LOS molecule of C. jejuni exhibits pleiotropic effects. The LOS is a major surface 
component, which is divided into two major parts, the lipid A and the core oligosaccharide 
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consisting of the inner core and the outer core. The core oligosaccharide contributes to the 
virulence of C. jejuni (24) and the induction of GBS (117). The lipid A of the LOS molecule 
possesses endotoxic properties (73). Expression of some of the LOS synthesis genes also 
results in multiple effects. For example, expression of the waaC gene affects both the LOS-
inner core synthesis and the capsule synthesis (45), while expression of the neuB genes affects 
both the LOS-outer core synthesis and the flagella synthesis (63). Another example is the htrB 
gene. It is involved in morphology, viability, growth capacity, and sensitivity to stress 
environments (Chapter IV). Based on this data, it will be clinically useful for further 
functional characterisation of the HtrB homologous proteins in other enteropathogens as these 
proteins may represent a new antimicrobial target(s) for chemotherapy.  
Both bacterial and host factors play an important role in GBS development. GBS is an 
autoimmune neuropathy, which can occur following a C. jejuni infection. It is known that 
some C. jejuni strains exhibiting human ganglioside-like LOS structures can induce GBS 
(117). The LOS synthesis genes, which are essential for the formation of this GBS-inducible 
determinant, include galE (94), wlaND (Viraj N. Perera, unpublished data, school of Applied 
Sciences, RMIT University, Australia), cgtA (35, 37), cgtB (62), cstII (35), neuB (63), neuC 
(35), neuA (35), and waaF (76). Other bacterial factors, including phase variation (37, 62, 88), 
natural transformation (Chapter I) have a potential effect on the expression of the GBS-
inducible determinant. Surprisingly, both DNA strands of the LOS synthesis gene cluster of 
GBS-inducing C. jejuni HB 93-13 are transcribed but transcription of the non-coding strands 
is at a lower rate, and both sense and antisense transcripts of each LOS gene tested are 
involved in regulating C. jejuni responses to acid stress (Chapter III). This unusual 
transcription might also be involved in the expression of the GBS-inducing determinant. A 
role of host factors in relation to GBS is implied by the fact that (i) a cross-reactive immune 
response to the C. jejuni LOS and the human gangliosides is rare following a C. jejuni 
infection (72, 103) and (ii) the same C. jejuni isolates are observed from both GBS and non-
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GBS patients (112). Although a number of investigators have been trying to link the host 
factors like HLA, the T cell receptor, and the LPS/LOS receptor (CD14 and TLR4) to GBS, 
direct evidence of these host factors in relation to GBS development has not been established 
and needs future research (27, 28, 38, 39, 60, 65, 66, 71, 89).  
CD14 and Toll-like receptor 4 (TLR4) are important in the presentation and 
intracellular signalling of LPS. CD14 is a 55-kDa glycoprotein, which is mainly expressed 
on mature monocytes, macrophages, and activated granulocytes (118). TLR4 is a 
transmembrane protein required for intracellular signalling. After the LPS molecule binds to 
its receptor, the CD14 and TLR4 complex, a cascade of intracellular events results in the 
activation of NF-κB, which in turn induces the transcription of several cytokine genes such as 
IL-1, IL-6, and TNF-α resulting in a pro-inflammatory environment (55). In the case of GBS, 
the induction of cross-reactive antibodies to the C. jejuni LOS and the human gangliosides 
may be caused by inappropriate activation of antigen presenting cells via the CD14-TLR4 
complex. However, polymorphisms in LOS receptors CD14 and TLR4 do not seem to be 
associated with disease susceptibility or C. jejuni infection in GBS patients (27). Therefore, 
other host factors involved in LOS presentation through the CD14-TLR4 complex, such as 
LOS-binding proteins, should be the focus of future investigations.  
Investigation of LOS-associated host proteins may unravel the pathogenesis of GBS. 
Three host proteins are well known to play an important role in host immune responses to the 
LPS of Gram-negative bacteria. These proteins are the 18-kDa cationic antimicrobial protein 
(CAP18, LL-37), the bactericidal permeability-increasing protein (BPI, CAP57), and the LPS 
binding protein (LBP). CAP18 is a human antimicrobial peptide released from activated
 
neutrophil granulocytes which binds to LPS and neutralises its various effects (57). BPI is a 
human antimicrobial peptide found in granulocytes and bone marrow-derived dendritic cells 
(19, 67). It binds to LPS near the lipid A domain, and formation of the LPS-BPI complex 
abrogates detrimental host responses to LPS (67). The mouse BPI is most strongly induced by 
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bacterial LPS through a signaling pathway that is completely dependent on its TLR4/IL-1 
receptor domain which induces the synthesis and secretion of IFN-β (19). Relation to GBS, 
the presence of BPI could prove valuable in prognosis as it will result in a reduced LOS 
responsiveness. LBP is an acute-phase protein that is mainly synthesised in hepatocytes and is 
released as a glycoprotein into the bloodstream. Other sources of LBP include epithelial cells, 
renal cells, and the central nervous system. At lower concentrations, LBP binds and transfers 
LPS to both the membrane bound (CD14-TLR4 complex) and the soluble form of CD14, 
resulting in the activation of host immune responses to the LPS (120). However, 
concentrations of LBP in human serum increase during an acute-phase response, and these 
increased LBP concentrations exhibit inhibitory effects in terms of cellular activation. 
Therefore, investigating the presence or absence of the LPS/LOS-binding proteins in GBS 
patients might lead to a better understanding of the development of GBS. Furthermore, 
comparative analysis of the genomes/proteomes of hepatocytes and peripheral blood 
mononuclear cells isolated from both GBS and non-GBS patients might lead to the 
identification of the host susceptibility genes/proteins.  
Vaccine development against C. jejuni faces serious challenges. To date, no effective 
vaccine is available. From the data presented in this thesis it is apparent that LOS should be 
used with caution as antibodies to LOS of some C. jejuni strains have been shown to cross-
react with human neuronal gangliosides (117). Furthermore, a live vaccine of C. jejuni should 
not be used as certain C. jejuni strains, such as C. jejuni 81116, can change both phenotype 
and genotype following natural transformation (Chapter I). In addition, this strain can 
transform from a non-GM1-expressing strain to a number of GM1-expressing strains (Chapter 
I), which have the potential to induce GBS (117). However, a vaccine containing killed 
bacteria lacking ganglioside-like LOS structures could be considered. Since C. jejuni exhibit 
genetic diversity among strains, immunity to Campylobacter appears to be strain-specific and 
not protective (10). Therefore, subunit vaccines seem to be more appropriate for this bacterial 
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pathogen. Antigenic determinants that are essential for survival, growth, resistance to stress 
environments, and/or virulence, such as the HtrB protein (Chapter IV) should be considered 
as candidates to be included as a subunit vaccine.  
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